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Abstract 
Hepatitis B virus (HBV) is one of the most common human pathogens. Chronic 
hepatitis B virus infection causes serious liver diseases such as cirrhosis and 
hepatocellular carcinoma. Since there is no effective drug for the treatment of 
hepatitis B and the common anti-HBV drugs cause many side effects, it is of clinical 
importance to develop a new effective drug against HBV. 
Phyllanthus species have long been used in folk medicine in China and most other 
countries for thousands of years for the treatment of hepatitis. Phyllanthus species 
have been proven to have anti-HBV effects by in vivo and in vitro experiments. In my 
project, three species, P. urinaria (葉下珠）from Guangdong, P. virgatus (黃珠子草） 
from Hainan and P. pendulus (印度葉下珠）from India were used to study and 
compare their anti-HBV effects. 
Alexander cell line (PLC/PRF/5) has been used to examine the anti-HBV 
activities of Phyllanthus species in vitro in the present study. This cell line possesses 
integrated hepatitis B virus genome and can secrete HBsAg into medium and is 
therefore an ideal in vitro model for screening the active component of Phyllanthus 
species. 
XVI 
We found that both aqueous and organic extracts of three phyllanthus species 
suppressed the Pre S and S viral gene expressions in cultured Alexander cells. P. 
pendulus from India showed the most significant effect. Other two species performed 
similar effectiveness, but they are less effective than P. pendulus from India. Besides 
the suppression of Pre S and S gene expressions, all aqueous extracts decreased the 
HBsAg secretion from cells to medium. However, organic extracts transiently 
increased the HBsAg secretion after 48 hours treatments. The level of intracellular 
p43 large hepatitis B surface (LHBs) polypeptide was decreased after 48 hours 
treatments of organic extracts but it was not affected by aqueous extracts. Therefore, 
the transient increase of HBsAg secretion from Alexander cells to medium after 
treatment of organic extracts may be due to the release of intracellular p43 LHBs 
polypeptide to medium. 
An active component, pheophorbide a, was isolated from the organic extract o^ P. 
urinaria from Guangdong. Pheophorbide a, with molecular weight 592.3, suppressed 
the Pre S and S gene expressions more effectively than its original crude extracts. 
Moreover, pheophorbide a inhibited the Pre SI promoter activity significantly, and 
that meant it exerts its effect directly against HBV. Therefore, pheophorbide a seems 
to be a highly potential therapeutic agent for hepatitis B. More in vitro and in vivo 
XVII 
studies and clinical trials are needed to fiirther confirm the anti-HBV effect of 






























CHAPTER 1 INTRODUCTION 
1.1 Hepatitis B 
1.1.1 Brief Introduction of HBV 
Hepatitis B is caused by the infectious Hepatitis B vims (HBV). HBV is 
estimated to have infected 350 million people throughout the globe (WHO, 1998), 
making HBV one of the most common human pathogens. Hepatocellular carcinoma 
(HCC), one of the most common cancers afflicting humans, is primarily caused by 
chronic HBV infection. 
In the last few decades, the correlation between HBV and the development of 
HCC has been well established. However, the mechanism by which HBV transforms 
hepatocytes remains elusive. Before HBV can transform a cell, the virus must first 
infect it. However, the mechanism through which HBV enters hepatocytes has not 
been resolved despite further understanding of the viral proteins involved. 
Vaccines are available against HBV, but they may not be absolutely effective 
against all variants of HBV. Furthermore, there is no cure for individuals already 
infected. Much more research is needed before we fully understand and control the 
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spread of this infectious agent. 
1.1.2 History of Hepatitis B Virus 
Viral hepatitis is the term reserved for infections of the liver by one or more of 
the distinct hepatitis viruses. The terms, hepatitis A and hepatitis B, were first 
introduced by MacCallum in 1947 in order to categorize infectious (epidemic) and 
serum hepatitis (MacCallum, 1947). These terms were eventually adopted by the 
World Health Organization Committee on Viral Hepatitis (World Health Organization, 
1973). 
Before the viruses causing hepatitis were isolated, transmission was 
differentiated on the basis of epidemiological observations. Type A hepatitis was 
considered predominantly transmitted via the fecal-oral route while type B hepatitis 
was believed to be primarily transmitted parenterally. 
In 1963, when searching for polymorphic serum proteins, Blumberg discovered a 
previously unknown protein in the blood of an Australian aborigine (Blumberg et al, 
1967). This protein was denoted as the Australia (Au) antigen. It became apparent that 
this protein was related to type B hepatitis. 
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By 1968, other investigators, notably Prince, Okochi, and Murakami, had 
established that the Au antigen was only found in the serum of type B hepatitis 
infected patients (Prince, 1968; Okochi and Murakami, 1968). This is now known as 
the hepatitis B surface antigen. 
In 1970, Dane found vims-like particles in the serum of patients suffering from 
type B hepatitis (Dane, 1970). These particles were designated as the hepatitis B virus 
(HBV). Non-related hepatitis viruses were discovered later, but the hepatitis B virus 
retained its name. 
Kaplan confirmed the viral nature of these particles by detecting an endogenous 
DNA-dependent DNA polymerase within its core (Kaplan, 1973). Discovery of this 
polymerase allowed Robinson and his colleague to detect and characterize the HBV 
genome (Robinson and Greenman，1974). The HBV genome is unique in the world of 
viruses due to its compact nature, use of overlapping reading frames, and dependence 
on a reverse-transcriptional step, though the virion contains primarily DNA. In light 
of this, the human hepatitis B vims became the archetype of the hepadnavirus family, 
Hepadnaviridae. 
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1.1.3 Hepatitis B Virus Infection around the World 
According to the report of World Health Organization (WHO) in 2000, HBV has 
infected over two billion people worldwide. Approximately 350 million are chronic 
carriers. Transmission of HBV is primarily through blood and/or sexual contact, 
though other methods of transmission have been suggested. 
The prevalence of HBV carriage varies among different regions. It ranges from 
0.1-0.2% in Britain to 10-15% in Africa and Far East. China and Southeast Asia are 
among the high prevalence areas with more than half of the population being infected 
some times in their lives, and more than 8 % are carriers. 
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Figure 1.1: Distribution of chronic hepatitis B infection around the world (Adapted 
from http://www.globalserve.net/~harlequin/HBV/). 
1.1.4 Hepatitis B Virus Infection in Hong Kong 
According to the research of Department of Health in 1998, about half of the 
adult population above the age of 40 have been infected with hepatitis B. About 40% 
of the adult have been infected with HBV and up to 25% of the carriers may 
eventually die of chronic liver diseases. 
It is shown that the HBV carrier rate in Hong Kong has been declining from 10% 
to about 7-8% in the past 20 years. The seroprevalence of hepatitis B virus (HBV) 
markers in Hong Kong population has continued to fall (SWGVHP: Department of 
5 
Health, 2000). This is due to vaccination program for all newborns, screening and 
prophylaxis measures, advanced diagnostic and therapeutic service, research activities 
as well as public education. 
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Figure 1.2: Estimated HBV carriage rate by age group in Hong Kong 
All epidemiological statistics were provided by Department of Health 
(http://www.info.gov.hk/hepatitis/einside.htm) 
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1.1.5 Hepatitis B Virus Infection in China 
1.1.5.1 Update of HBV Infection in China 
Hepatitis is commonly known as "The Chinese Disease". It implies the serious 
impact the disease has on Chinese, much more than any other races. In China, 
hepatitis B infection rate is 60% and about 10% (130 million people) are chronic 
hepatitis B carriers (Dai and Qi, 1997). It is estimated that 15%-25% of these chronic 
HBV carriers (about 20 million people) will die eventually from liver disease, such as 
liver failure, cirrhosis or hepatocellular carcinoma (Mast and Alter, 1993). 
There are sex and regional differences in the chronic carrier rate in China. The 
chronic carrier rate of women is much lower than men, and is higher in rural areas 
compared with urban areas (Guang, 2000). 
1.1.5.2 Problems in China 
The most common transmission of HBV infection in China is maternal to infant. 
About 40% of newborns are carriers due to their mothers being positive for HBsAg. 
80-90% in newborns are bom by mothers positive for both HBsAg and HbeAg (Lai, 
1998). 
7 
Transfusion, nosocomail infection, and micro-blood contacts cause HBV spread 
in society, especially serious in HBV infection in families (Lai, 1998) 
Although HBV prevention in China started in 1985 as part of the World Health 
Organisation's expanded program of immunization, and involved vaccination of all 
neonates and infants (Guang, 2000). Vaccination coverage in rural areas tends to be 
low as of variation in economic conditions and transportation (Cao et ai, 1995). 
For immunomodulatory therapy, interferon alpha is available, but expensive, 
inconvenient to administer (by subcutaneous injection) and poorly tolerated 
(Hoofnagle and Di Bisceglie, 1997). In addition, many Chinese patients fail to 
respond to this agent (Lok et al., 1992; Wong et al., 1993). 
1.2 Hepatitis B Virology 
1.2.1 Hepadnaviridae Family 
Hepatitis B vims belongs to the family of Hepadnaviridae, which includes various 
closely related viruses that infect birds and mammals (Ganem, 1996). The woodchuck 
HBV (WHBV) and duck HBV (DHBV) have proven to be useful animal models for 
elucidating the replication and persistence of HBV infection. All these viruses show 
8 
hepatotropism, to a greater or lesser degree, and have narrow host-range specificity. 
Therefore, HBV infects only human beings and chimpanzees, while none of the 
animal Hepadnaviridae infects human beings. 
1.2.2 HBV Particle Types 
Infectious and non-infectious particles can be found in high abundance within 
the serum of an acutely infected individual. The infectious hepatitis B virion (Dane 
particle) is a 42-nm particle. The outer envelope contains high amounts of hepatitis B 
surface proteins. The envelope surrounds the inner nucleocapsid which is comprised 
of 180 hepatitis B core proteins (Crowther et al, 1994). The nucleocapsid also contains at 
least one hepatitis B polymerase protein as well as the HBV genome (Gerlich and 
Robinson, 1980). 
Two other subviral particles, filament and sphere can be found in an infected 
individual's serum (Dne et al., 1970). Both particles have a diameter of 22nm and are 
composed of hepatitis B surface proteins. The absence of the hepatitis B core, 
polymerase, and genome reflects these particles' non-infectious nature. The sphere is 
composed of the small (SHBs) and middle hepatitis B surface (MHBs) proteins 
whereas the filament also includes the large hepatitis B surface (LHBs) protein. 
9 
PKC 卷 hepatitis B virus 
r i f \ ^ ^ 
17-25 nm 
^ W filaments 
Figure 1.3: Schematic model of the HBV and HBs particles (Adapted from Kann and 
Gerlich, 1998). 
1.2.3 The HBV Genome 
The viral genome consists of a circular, partially double stranded DNA molecule, 
approximately 3200 base pairs in length (Robinson et al., 1974). There are four 
defined overlapping open reading frames (ORFs) in the genome which result in the 
transcription and expression of the seven different hepatitis B proteins. The four ORFs 
10 
lead to the transcription and translation of nucleocapsid, envelope, polymerase and X 
protein through use of varying in-frame start codons. ORF P occupies the majority of 
the genome and encodes for the polymerase protein. ORF S encodes the three surface 
proteins (Heermann et al., 1984). ORF C encodes both the hepatitis e and core protein 
(Ou et al,, 1986). ORF X encodes the hepatitis B X protein (Kwee et al., 1992). There 
are at least seven major subtypes of HBV, distinguished by sequence differences in 
the surface antigen gene (Raney and McLachlan, 1991). 
I t ~ ^ ^ ^ ^ ^ ^ ^ 
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Figure 1.4: Genetic map of HBV, showing the four open-reading frames and the two 
major transcripts (Adapted from Vyas and Yuen, 1999). 
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1.2.4 The Life Cycle of HBV 
Attachment 
Hepatitis B vims attachment is one of the crucial steps that determine among 
other factors the host range and organ tropism of viruses. An organ- and host-species 
attachment of serum-derived hepatitis B surface (HBs) proteins was found by Neurath 
et al with HepG2 cells (Neurath et al, 1986), but not with animal liver cells or human 
carcinoma cells of nonhepatic origin. The binding was proven relating to the pre SI 
sequence 21 to 47. Monoclonal antibodies to this region could block attachment to 
HepG2 cells or infectivity for primary human hepatocyte cultures (Petit et al., 1991; 
Petit et al., 1992). Recent observations suggest that middle hepatitis B surface antigen 
may be dispensable for infectivity in vivo (Fmholz et al., 1993). However, the small 
hepatitis B surface (SHBs) protein does not involved directly in attachment, but it 
attaches to hepatocyte-bound endonexin II (Hertogs et al., 1993). 
Virus Penetration 
The mechanism of HBV entry into hepatocyte is not clearly defined. The studies 
suggest that a proteolytic event must occur on the large surface protein to expose a 
membrane fusion domain (Lu et al., 1996). However, it is believed that this occurs at 
the plasma membrane and not within an acidic vesicle (Kock et al., 1996). 
12 
Genome Release 
After penetration, the core particle is believed to be transported to the nuclear 
membrane. Since the maximal diameter of nucleus of the nuclear pore of 25nm is 
exceeded by the experimentally determined size of the core particle of 36nm(Guidotti 
et al., 1994), the function of core particle is to mediate the transport of the viral 
genome to the nuclear pore complex if it is phosphorylated (Qiao et al., 1994). 
Subsequently, release of the viral genome must happen, followed by the nuclear 
import of the viral genome. This can be mediated by the covalently bound viral 
polymerase (Kann et al., 1997). 
HBV Genome Repair and Transcription 
The HBV DNA is brought into the nucleus where it is repaired to the covalently 
closed-circular form (cccDNA). Repair requires completion of the dsDNA form, 
removal of the 5' terminal structures (an RNA primer and the polymerase protein), as 
well as covalent ligation of the strands. The hepatitis B polymerase protein is not 
required for these steps to occur (Kock et al., 1993). Unlike the retroviridae, 
integration of HBV DNA into host cell DNA is not required for replication. In fact, 
integration of HBV DNA results in the disruption of one or more HBV ORFs and 
prevents transcription of functional pregenomic RNA. 
13 
Once recircularized of viral genome, enhancer and promoter activities start 
producing the various HBV transcripts required for HBV protein synthesis and 
pregenomic RNA generation. The transcripts generated can be divided into two 
categories: subgenomic and genomic. The smaller, subgenomic transcripts serve as 
mRNA for the expression of the X and surface proteins. The larger genomic 
transcripts are longer than one genome in length and serve to produce e, core and 
polymerase proteins. A particular genomic transcript, lacking the ATG start codon for 
the e protein, is designated the pregenomic RNA since it is chosen specifically by the 
HBV polymerase protein for packaging (Enders et aL, 1987). 
Assembly of Virions and release of the virus 
After translation of various kinds of proteins, the pregenomic RNA is then 
transported into the cytoplasm and, together with the viral polymerase, incorporated 
into new nucleocapsid particles. Inside the particles, the pregenomic RNA is 
reverse-transcribed into DNA minus strands. This replication strategy via an RNA 
intermediate represents a unique mechanism during the replication of the HBV virus 
(Summers and Mason, 1982). As a last step, plus-strand DNA is produced, so that 
partially double-stranded viral DNA genome is completed again. Nucleocapsids 
14 
containing viral genomes can then be retransported into the nucleus to amplify the 
HBV copy number in the cell (Tuttleman et ah, 1986) or acquiring the outer envelope 
shell to form 42nm virions in endoplasmic reticular(ER). 
The transcripts for LHBs, MHBs and SHBs are translated at the rough ER and 
the HBs proteins are inserted in that membrane. Regions high in SHBs protein, with 
minimal MHBs, are able to bud into the lumen of the ER to produce the secreted 
22nm HBs particles (Chisariet et al., 1986). LHBs rich ER membrane areas result in 
retention of core particles (Standring et al., 1986) to form virions. The virions and 
HBs particles are then secreted by the constitutive secretory pathway. 
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Figure 1.5: The life cycle of HBV (Adapted from Zuckerman and Thomas, 1998). The 
virus is endocytosed after attachment. The nucleocapsid is released to the cytosol and 
binds to the nuclear pore. The genome is transported into the nucleus, converted to 
cccDNA, and transcribed to three essential classes of mRNA. Translation of the 
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core/polymerase transcript in the cytosol allows for assembly of core particles that the 
progenome are inserted in that membrane. The HBs particles bud to the intermediate 
compartment, and at least a part of LHBs-rich ER-membrane areas envelopes core 
particles. The HBV and HBs particles are secreted thereafter by the constitutive 
pathway. 
1.2.5 Hepatitis B Surface Antigen (HBsAg) 
Hepatitis B surface antigen (HBsAg) is composed by large, middle and small S 
protein. The most abundant is the small S (SHBs) protein (24kDa) coded by the S 
gene only. The middle S (MHBs) protein (31kDa) is a product of preS2 and S genes 
(Stibbe and Gerlich, 1983), whereas the large S (LHBs) protein (39kDa) is encoded 
by the preSl, preS2 and S genes (Heerman et al., 1984). The LHBs protein is 
predominantly present on the surface of virions. 
These three proteins are targeted to the ER by an internal signal sequence, where 
they assume the configuration of a transmembrane protein (Eble et al., 1986). These 
proteins are linked by disulfide bonds into homo- or heterdimers, then self-aggregate 
into large polymers (Wounderlich and Bruss, 1996). 
17 
Unlike the envelope proteins of other virus, the MHBs and SHBs proteins are 
secretion-competent in the absence of the nucleocapsid or any other HBV proteins. 
They form subviral particles, which are present in the serum of HBV-infected 
individuals mainly as 20-nm spheres and filaments. In contrast, the LHBs protein 
cannot be secreted by itself but only when coexpressed with other surface proeins. A 
small portion of LHBs protein results in the production and secretion of HBV subviral 
particles of spherical shape, whereas a larger amount of LHBs protein results in the 
formation of filaments that are inefficiently secreted (Molnar et al., 1988). Moreover, 
these particles more likely accumulate in intracellular compartments, probably 
because they are held back by cellular chaperones such as calnexin (Xu et al., 1997). 
The overproduction of the LHBs protein, leading to intracellular accumulation of 
surface proteins, is a common event during chronic HBV infection. Large amount of 
the non-secreted surface proteins accumulate within the hepatocytes, resulting in 
ground-glass cells (Chisari et al., 1986). The molecular basis for large surface protein 
over expression in human hepatocytes is unknown. Since these cells usually arise at a 
late stage of infection, when the viral core protein expression and viremia are both at 
low or non-detectable levels, it has been suggested that perhaps this alteration in gene 
expression is because of from viral DNA integration (Dienes et al., 1990). 
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1.3 HBV Transmission 
HBV is passed on by exchange of blood and body fluids, such as sexual contact, 
sharing hypodermic needles, from mother to baby and blood contact. In areas of high 
endemicity such as China, transmission from an infected mother to child is the main 
mode of transmission. Prenatal transmission rates from HBsAg-positive mothers are 
as high as 90% (Margolis et al., 1991). Infections are generally acquired early in life, 
either at or shortly after birth, or early in childhood from exposure to members of the 
extended family who may be carriers of HBV (Gust, 1996). 
1.4 HBV Therapy 
The WHO Expanded Programme of Immunisation (EPI) Global Advisory Group 
called for all countries to add the hepatitis B vaccine to their national immunization 
programmes in 1991(Davey, 1996). Eighty countries had achieved this goal in 1998, 
and a further 10-20 countries plan to do so over the next few years (Kane, 1998). 
World-wide population-based studies of hepatitis B immunisation show reductions in 
the incidence of chronic HBV infection from 8% or greater to less than 2% in 
immunized cohorts of children. 
Although vaccination programmes have begun to control the spread of HBV, therapy 
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is the only option for those with established chronic HBV-associated liver diseases. 
Two therapeutic approaches have been used to prevent hepatitis B viral replication: 
immunomodulators, such as Interferon-a and interleukin-2, and nucleoside analogues, 
such as lamivudine, famciclovir and acyclovir. 
Interferon-a (IFN-a) is a naturally occurring proteins secreted by many 
mammalian cells in response to viral infection. IFN-a has antiviral, and 
immunomodulatory effects. For antiviral effects, it inhibits viral proteins synthesis via 
inducting an increase in the intracellular level of 2,,5,-oligoadenylate synthetase 
(Fujisawa et al., 1987), which activate ribonucleases to cleave viral mRNA. For 
immunomodulatory effects, it increases both specific (cytotoxic T lymphocytes) and 
nonspecific (natural killer cell) immune response to viral proteins (Davis and 
Hoofnagle, 1986). 
Adverse effects of interferon-a treatment are flulike, hematological, emotional, 
autoimmune, and miscellaneous. Major side effects are summarized in Table 1. 
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General Immunological Hematological Psychiatric 
Flulike symptoms, Autoantibody Granulocytopenia, Impaired concentration, 
Fever; Myalgias, production, Leukopenia, Depression 
Arthragias, Thyroid dysfunction. Thrombocytopenia. Irritability. 
Headache. 
Table 1.1: Side effects of interferon-a therapy (Steven et al； 1997) 
Many clinical trials of Chinese patients suggest that, even though these patients 
may benefit from IFN-a as compared with untreated controls (Wong et al., 1993), 
they respond relatively poorly to IFN-a (Lai et aL, 1998). 
Lamivudine is another common antiviral drug for hepatitis B. From the clinical 
studies, lamivudine is more tolerable than IFN-a and has a safety profile similar to 
that of placebo. Treatment with lamivudine may also be claimed to be more 
cost-effective than IFN-a (Lacey et al, 1999; Haiderali et cd., 1999). 
Lamivudine is the (-) enantimoer of the deoxycytidine analogue 
2'-deoxy-3 '-thiacytidine. It undergoes phosphorylation by intracellular kinase to form 
the active 5'-triphosphate form (Cammack et cd., 1992), which is a substrate for HBV 
polymerase. HBV replication is prevented by competitive inhibition of viral reverse 
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transcriptase and termination of proviral DNA chain extension. 
The most significant limitation to long-term treatment by lamivudine therapy for 
chronic HBV has been the emergence of resistant HBV mutant of YMDD 
(tyrosine-methionine-aspartate-aspartate) motif. Since YMDD motif situates centrally 
in the DNA polymerase gene close to the putative lamivudine binding site (Allen et 
al” 1998)，the mutation weakens the inhibitory effect of lamivudine. 
A variety of plant extracts are used in the treatment of chronic hepatitis B 
primarily in Asia for thousands of years. Since the objective assessment of these 
therapies is hindered by the poorly defined nature of some of the extracts and trials 
reporting efficacy are often uncontrolled, therefore, many researches of natural 
products for anti-HBV have undergone investigation. 
1.5 Phyllanthus Species 
Phyllanthus belongs to the family of Euphorbiaceae. There are about 550 to 750 
species distributed through out most tropical and subtropical countries (Calixto et al., 
1998). Phyllanthus species have long been used in folk medicine in Asia, Africa and 
South and Central America for thousands of years (Thyagarajan et al., 1988). 
22 
p. amarus have been studied for pharmacologically active substances and for its 
therapeutic effects. Alkaloids, flavonoids, lignans and an angiotensin converting 
enzyme inhibitor were isolated from these species (Calixto et al,, 1998 and Uneo et 
al., 1988). The traditional diuretic action has been confirmed and the inhibition of 
induced liver injury reported (Syamasunder et al., 1985). Recently, many studies 
focus on the anti-HBV activity of Phyllanthus species. 
Thyagarajan et al. first demonstrated that the extract from the plant P. amarus 
produced consistent inhibition of HBsAg in in vitro studies (Thyagarajan et al., 1976). 
P. amarus (originally classified as P. niruri) also inhibited viral DNA polymerase 
activity and bound to the HBsAg in vitro (Venkateswaran et al., 1987). Further studies 
showed that P. amarus inhibited HBV polymerase activity, decreased episomal HBV 
DNA content and suppressed vims release into culture by using the cell line 
HepG2.2.15 which support the HBV replication (Lee et al., 1996). For transgenic 
mice study, the decline of HBsAg mRNA after administration of P. amarus indicated 
transcriptional or post-transcriptional down-regulation of the transgene (Lee et al., 
1996). The extract of P. amarus and P. uriniria could suppress the HBsAg secretion 
from Alexander cells (Ji et al., 1993; Jayaram and Thyagarajan, 1996). Later on, it 
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was found that P. amarus extract could suppress HBV mRNA transcription by 
interrupting interactions between HBV enhancer I and cellular transcription factors 
(OTT et al., 1997). Taken together, such findings were indicative that some 
Phyllanthus species have a beneficial effect against the HBV, possibly through 
inhibition of polymerase activity, mRNA transcription and replication. 
For animal studies, five long-term woodchuck hepatitis vims (WHV) carriers 
treated with amarus showed a faster decrease in Woodchuch HBsAg titer compared 
to one untreated control (Venkateswaran et al., 1987). R uriniria form Guangxi and 
Yunna could lower the serum duck hepatitis B vims (DHBV) DNA significantly 
(Chen et al” 1995). However, the results of some reports were controversial. For 
examples, the duck congentially infected with DHBV did not result in any significant 
reduction of the circulating viral DNA in the serum and the level of viral DNA 
replication in the liver (Niu et al., 1990). Moreover, similar study suggested that P. 
amarus and P. maderaspatensis were not useful as therapeutic agents for post 
exposure prophylaxis against DHBV infection (Munshi et al., 1993). Such 
contradictory findings can be due to the combination of many factors such as 
variations in plant material of animal species, period and place where the botanical 
samples were collected, age of plants and the part of the plant used. 
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Liu et al. performed a systematic review of randomized clinical trials to evaluate 
the efficacy and safety of genus Phyllanthus for chronic HBV infection (Liu et al., 
2001). Totally 219 articles concerning genus Phyllanthus were collected. Some 
articles were excluded because they did not meet their inclusion criteria. By 
combining the results of four placebo-controlled trials, Phyllanthus vs. placebo had an 
effect on clearance of serum HBsAg, but no effect on clearance of serum HBeAg 
could be observed. Compared with nonspecific treatment trials, Phyllanthus species 
caused the clearance of serum HBsAg and HBV DNA. Phyllanthus species did not 
exhibit toxicity to liver, since serum ALT, AST and total bilirubin remained normal 
after treatment. The review also reported that the combination therapies of 
Phyllanthus herb and interferon showed a better effect on the clearance of HBeAg 
than interferon alone. The combination had a better effect on normalization of serum 
ALT and AST. By summarizing the trials of Phyllanthus species vs. other herbal 
medicines for anti-HBV, Phyllanthus species such as P. amarus, had significant 
effects on antiviral activity and normalization of liver enzymes than other herbal 
medicines. 
Although some clinical trials showed positive effects of Phyllanthus species on 
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the clearance of HBV markers and on normalization of liver enzymes with no serious 
adverse effects, the majority of many trials had poor methodological quality and small 
sample size (Liu et al., 2001). Therefore, carefully designed, larger randomized, 
double-blind, placebo-controlled trials are required to evaluate the efficacy of 
Phyllanthus species in chronic HBV infection. 
Even though there were many studies supporting the beneficial effects of 
Phyllanthus species against HBV, the mechanisms of their action are still not clearly 
defined. Moreover, the active component(s) responsible for anti-HBV is(are) still 
unknown. 
1.6 Alexander Cells 
Alexander (PLC/PRF/5) cell line is a human hepatoma cell line. This cell line 
was established by Alexander et al (1978) from hepatocelluar carcinoma of a 
24-year-old Mozambican man with HBsAg in his liver cells in 1976. One of the 
properties of this cell line is secretion of 22-spherical particles of HBsAg into culture 
medium (Alexander et al., 1978). Alexander cells have an epithelial morphology and 
secrete proteins characteristic of differentiated liver cells, but do not produce HBV 
virion and other viral protein except HBsAg (Aden et al., 1979 and Knowles et al., 
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1980). Analysis of the integrated HBV DNA demonstrates that this cell line at least 
contains seven copies of HBV DNA integrated in its genome (Ou et al., 1985). No 
full-length viral genomes have been integrated, instead of integration of viral DNA 
fragments that are frequently rearranged (Edman et al., 1980 and Twist et al., 1981). 
Ou et al. (1985) characterized the HBV-related RNA in Alexander cells. The 
HBV RNAs comprise only 0.05% of the total cellular mRNAs. The great majority of 
this viral RNA is derived from the surface antigen gene. The seven integrated HBV 
sequences were cloned and sequenced. It was found that only two integrated 
fragments contain both viral promoter and enhancer region and other fragments only 
contain either one (Ou et al., 1985). It is possible that insertion mutagenesis may be 
related to HBV-associated hepatic carcinogenesis. 
The polypeptides of HBsAg produced by PLC/PRF/5 cells have also been 
studied (Marion et al., 1979; Qu and Rutter, 1985). The major polypeptides of 
serum-derived HBsAg particles (p20, p23 and p25) were found in the particles from 
this cell line. The other three minor polypeptides (p31, p36 and p43) were also 
detected by immunoprecipitation with anti-HBs. However, the two largest 
polypeptides of serum particles (p49 and p66) were not detected. 
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The immunnohistochemical studies showed that intracellular HBsAg is located 
in the cytoplasm and on the surface of tumor cells (Daemer et al., 1980; Gerber et al., 
1981; Wen et al., 1981). For ultrastmctural analysis of HBsAg production of 
PLC/PRF/5 cells, HBsAg is expressed on rough-surfaced ER and in cistemae of ER 
(Aoki et al., 1982). This distribution is identical to that observed in hepatocytes of 
patients infected with HBV. This observation suggests that HBsAg is synthesized on 
rough-surfaced ER and transferred into endoplasmic cistemae for processing and 
secretion. 
Although, the HBV genome integrated PLC/PRF/5 cells mainly express HBsAg 
viral protein, this cell line offers the first opportunity to study the formation of HBsAg 
at the molecular level in vitro. Therefore, the detail biochemical steps and regulation 
of synthesis, processing and secretion of HBsAg can be studied. In addition, the 
PLC/PRF/5 cell line is useful to study the possible relation of HBV and its genome, 
which is integrated into the cellular DNA of hepatocellular carcinoma. 
28 
1.7 Objectives 
One of the objectives of this study was examination and comparison the 
anti-HBV effects of three Phyllanthus species in vitro by using the Alexander cells. 
Another part of this thesis describes the experiments on isolation of the active 
component from the organic extract of P. urinaria from Guangdong. Finally, the 
effects of extracts and active component on Pre S1 promoter were studied. 
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CHAPTER 2 COMPARISONS OF AQUEOUS AND ORGANIC EXTRACTS 
OF THREE PHYLLANTHUS SPECIES OF THEIR IN VITRO ANTI-HBV 
EFFECTS 
2.1 Introduction 
Several Phyllanthus species have been shown to have the anti-HBV effects in 
vitro. Therefore, the aqueous and organic extracts of three Phyllanthus species, two 
from China and one from India were used to examine and compare their anti-HBV 
effects. For the in vitro study, the HBV genome integrated cell line, Alexander cell 
line, was used. 
2.2 Materials and Methods 
2.2.1 Materials 
2.2.1.1 Phyllanthus species 
P. urinaria, Linn.(葉下珠)from Guangdong was bought from Yi Zhi Yao Dian 
(一致藥店)in Shenzhen. P. virgatus, Forst.(黃珠子草)was collected from Hainan. 
The Indian species, P. pendulus, Roxb.(印度葉下珠)，was kindly provided by Prof. 
P .C. Leung of the Institute of Chinese Mdicine, The Chinese University of Hong 
Kong. 
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2.2.1.2 Chemicals, Antibodies and Instrument 
Chemicals 
5X loading buffer Fermentus 
5X lysis buffer Promega 
Acrylamide USB 
Ammonium persulphate USB 
Agarose Invitrogen 
Bio-Rad Protein Assay Bio-Rad 
Bisacrylamide USB 
Chloroform BDH Laboratory Suppliers 
Diethyl pyrocarbonate (DEPC) Sigma 
Dexamethasone (DMSO) Sigma 
DNA molecular marker lOObp Fermentus 
dNTP Fermentus 
ECL Western Blotting Detection Reagent Amersham 
Ethidium bromide USB 
Ethanol BDH Laboratory Suppliers 
Fetal bovine serum Invitrogen 
Glycine USB 
Gene specific primers Invitrogen 
IMx HBsAg (V2) ABBOTT Diagnostics Division 
Isopropanol BDH Laboratory Suppliers 
Methanol BDH Laboratory Suppliers 
Minimum Essential Medium Invitrogen 
MTT Sigma 
N,N,N, ,N,-tetramethylethylenediamine (TEMED) Invitrogen 
Non-essential amino acids Invitrogen 
Oligo dT primers Invitrogen 
Phosphate buffered saline (PBS) Invitrogen 
Penicillin-Streptomycin-Neomycin(PSN) antibiotic Invitrogen 
Prestained protein molecular weight standard Fermentus 
RNase inhibitor Invitrogen 
RPMI medium Invitrogen 
Sodium Dodecyl Sulfate (SDS) Sigma 
superscript II reverse transcriptase Invitrogen 
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Taq polymerase Invitrogen 
Tris base USB 
Tween-20 USB 
TRIzol reagent Invitrogen 
Antibodies 
Anti-actin Oncogene 
Anti-HBsAg Zymed Laboratories 
Anti-receptor binding fragment, Pre S Biogenesis 
Horseradish peroxidase conjugated secondary antibody Zymed Laboratories 
(Mouse) 
Horseradish peroxidase conjugated secondary antibody Zymed Laboratories 
(Rabbit) 
Instruments 
Film Cassette Amersham 
GeneAmp® PCR System 9700 Applied Biosystems 
Immobilon-P transfer membrane Millipore 
Imx machine ABBOTT Diagnostics Division 
Mini PROTEIN® 3 gel electrophoresis apparatus Bio-Rad 
Microplate reader Bio-tek Instrument Inc 
Power supplier Major Science 
Spectrophotometer Bechman 
Thicker blotter paper Whatman 
TransBlot® SD Semi-Dry Transfer cell Bio-Rad 
X-rays film Fuji 
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2.2.2 Extraction Methods 
2.2.2.1 Aqueous Extraction 
The dried plant was boiled in water in a ration of one to five for two hours twice. 
The aqueous extract was filtered by using filter paper to remove insoluble debris, then 
the extract was frozen and lyophilized into powder form. The dried extracts were 
stored in vacuum bottles before used. 
2.2.2.2 Organic Extraction 
1kg dried plant was refluxed in 5L chloroform for one hour twice. Then, the 
plant was extracted with 5L of methanol for two hours twice. After methanol was 
evaporated from the extract, the extract was dissolved in ethanol. Afterwards, 
insoluble debris was removed. Finally, organic extract was obtained after evaporation 
of ethanol. 
2.2.3 Cell line 
The human hepatoma Alexander (PLC/PRF/5) cells, purchased from American 
Type Culture Collection (ATCC), were cultured in Minimum Essential Medium 
(MEM) supplemented 7.5 % sodium bicarbonate, 0.1 mM non-essential amino acids, 
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IX Penicillin-Streptomycin-Neomycin (PSN) antibiotic and 10% fetal bovine serum 
in 37°C humidified 5 % incubator. 
2.2.4 Toxicity of Extracts 
For toxicity test, MTT assay was performed. After the cells were treated for 
desired hour, the medium was discarded and the cells were washed with 100|il PBS. 
50^1 of MTT solution [0.1ml MTT stock (15mg/ml in PBS) in 2.4ml medium without 
serum] was added. The cells were incubated at 37°C for 2-4 hours. After the purple 
crystal was observed, MTT solution was discarded and 100|il of acidified isopropanol 
(0.4N HCl in isopropanol) or DMSO was added. The cells were allowed to incubate at 
room temperature for 15min. The plate was shaken for 5 seconds before the 
absorbance at 540nm was measured. 
2.2.5 IMx Assay 
The culture medium was collected after drug treatment. After spinning down the 
cell debris, 200|il culture medium was added to reaction cell provided from the 
reaction kit. Before running the reaction, the probe was cleaned by 75% methanol. 
After applied washing buffer and reaction kit into the IMx machine, the running 
program was started. The result was printed out about after one hour when the 
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reaction was completed. 
2.2.6 Semi-quantitative RT-PCR 
2.2.6.1 RNA Extraction 
For 100mm culture dish, the cells were washed by PBS for twice. Then, cells 
were lysed directly by adding 1ml TRIzol reagent. The homogenized samples were 
incubated at R.T. for 5 min to complete dissociation of nucleoprotein complexes. 
0.2ml of chloroform was added per 1ml of TRIzol reagent. The samples were shaken 
vigorously by hand for 15 seconds and incubated at R.T. for 2 to 3 min; the samples 
were centrifUged at I2000xg for 15 minutes at 2 to 8°C. The aqueous phase 
supernatant was collected. 0.5 ml of isopropyl alcohol was added to precipitate the 
RNA from the aqueous phase. The samples were centrifuged at 12000xg for 10 
minutes at 2 to 8°C after incubating at R.T. for 10 minutes. The supernatant was 
removed. The RNA pellet was washed with 1ml 75% ethanol. After centrifugation at 
7500xg for 5 minutes at 2 to 8°C, the ethanol was discarded. The RNA pellets were 
air-dried for 5-10 minutes. Finally, the RNA was dissolved in 20|li1 of DEPC water. To 
completely dissolve, the RNA was incubated at 55°C water bath for 10 minutes. 
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2.2.6.2 RT-PCR 
cDNA was synthesized first. 5 jig of total RNA was mixed with Ijil of 500|ig/ml 
oligo(dT)18 and l|il of lOmM dNTP mix, and then distilled water was added to make 
up to I2[i\. The mixture was heated to 65°C in a PCR machine for 5minutes and then 
quick chilled on ice. After briefly centrifugation to collect the contents in the tubes, 
4jal of 5 times First-strand buffer, 2^1 of O.IM DTT and \\x\ of RNase inhibitor were 
added to the contents. The contents of the tube were mixed gently for incubating at 
42°C for 2 minutes, lul of 200unit SuperScript II was added. The mixture was mixed 
by pipetting up and down. Afterwards, the samples were further incubated at 42°C for 
50 minutes. The reaction was inactivated by heating at 70°C for 15 minutes. 
Reverse-transcribed cDNA from each sample was amplified by polymerase chain 
reaction (PCR) using corresponding primers. Amplification was carried out using 
GeneAmp® PCR System 9700 in the following conditions: denaturation at 94°C for 
30 seconds, annealing at 50-65°C for 30 seconds and extension at 72°C for 30 
seconds, following by incubation at 72°C for 10 minutes. The PCR products were 
resolved on 1% (W/V) agarose gels by electrophoresis. DNA was stained with 
ethidium bromide and visualized under an UV-tranilluminator. 
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2.2.7 Western Blotting 
2.2.7.1 Preparation of Protein Samples 
After treatment, the cells were washed by PBS twice, and then lysed by 5X lysis 
buffer. The cell lysate was collected in 1.5ml microfuge tube. After vortexing the cell 
lyaste for 30sec, the cell lysate was boiled in water for 20min. The protein samples 
were kept at -80°C until further analysis. 
2.2.7.2 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was performed according to the method of Laemmli (1970). The gel 
was casted according to the instruction manual in the Bio-Rad Mini PROTEIN® 3 gel 
electrophoresis system. 15-30ug protein samples were resolved in polymacrylamide 
gel electrophoresis. The stacking and separating gels were 4.5% / 12% and 4.5% / 
15% respectively for protein with high molecular weight and low molecular weight 
respectively. The separating gel was prepared by mixing appropriate amount of 
acrylamide / bisacrylamide with N,N,N ‘ ,N ‘ -tetramethylethylenediamine (TEMED) 
and 0.05% ammonium persulphate in IX separating buffer (0.375M Tris base, 0.1% 
SDS, pH8.8). The stacking gel was prepared by mixing appropriate amount of 
acrylamide / bisacrylamide with TEMED and 0.075% ammonium persulphate in IX 
stacking buffer (0.125M Tris-base and 0.1% SDS. PH6.8). The gels were set in the 
37 
Mini PROTEIN® 3 gel electrophoresis apparatus. All the protein samples were 
diluted with water to the same final protein concentration before mixing with 5X 
loading buffer. The diluted samples were loaded onto the gel and run in IX running 
buffer (25mM Tris-base, 0.19M glycine and 0.1% SDS, pH 6.8) at 200V for 60 
minutes. The prestained protein molecular weight standard was used as marker. 
2.2.7.3 Protein Transfer 
After the proteins were separated, the gel was removed from the apparatus for 
electroblotting. Firstly, thick blotter papers were soaked in electroblot transfer buffer 
(25mM Tris base, 0.19M glycine and 10% methanol) and onto the platinum anode of 
the TransBlot® SD Semi-Dry Transfer cell. Then immobilon-P transfer membrane 
was wet in 100% methanol for 1-2 seconds and equilibrated in the electroblot transfer 
buffer for 5 minutes. The equilibrated membrane was placed on the blotter paper. 
Subsequently, the gel was rinsed with the electroblot transfer buffer and placed to the 
top of the membrane. Another piece of blotter paper was pre-soaked in electroblot 
transfer buffer, placed onto the gel and the stainless steel cathode was placed onto the 
stack. The separated proteins were transferred from the gel to the membrane for 60 
minutes at 15 V and the blotted membrane was used for antibody probing. 
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2.2.7.4 Immumnoblotting 
The membranes were rinsed by water and then blocked with 5% non-fat milk 
with 0.1% Tween 20 for 60 minutes. The membranes were incubated with the 
corresponding primary antibody (actin, HBsAg and receptor binding fragment, preS) 
for overnight with continuous shaking. The unbound primary antibody was washed by 
IX PBS with 0.1% Tween 20 three time for 15 minutes. Subsequently, the membranes 
were incubated with horseradish peroxidase conjugated secondary antibody for 1 hour 
with continuous shaking. The unbound secondary antibody was washed away with IX 
PBS with 0.1% Tween 20 for 15 minutes three times. The signals were detected by 
enhanced chemiluminescence (ECL). 1ml of ECL Western Blotting Detection 
Reagent 1 and 2 were mixed. The washed membranes were placed into the mixed 
reagent and incubated for 1 minute. The membranes were then wrapped in a 
ceramic-wrap and air bubbles were smoothed out. Finally, the membrane with the 
protein side up was placed into film cassette and the signal was detected by the 
exposure to the X-ray film. 
2.2.7.5 Protein Assay 
The protein assay was performed by using Bio-Rad Protein Assay. 2 \i\ of protein 
samples were diluted to 400X in final volume 800 i^l in duplicate. Albumin at 
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different concentrations was used to generate a standard curve for the protein samples. 
After mixing the protein samples with 200 |il dye reagent concentrate, the samples 
were incubated at room temperature for 10 minutes for color development. 
Absorbance was read at 595 nm. The concentration of the protein samples was 
calculated by the protein standard curve from albumin. 
2.3 Results 
2.3.1 Toxicity of the Extracts 
For in vitro study, the toxicity test was performed by the MTT assay in order to 
estimate the toxic effect of extracts on Alexander cells. 
The organic extract did not dissolve in water. Therefore, the appropriate solvent 
must be chosen for it. The criterion of appropriate solvent is that it would not cause 
the toxic effect to the cells. Three organic solvents, methanol, ethanol and DMSO, 
were chosen for the toxicity test. These solvents showed different toxic effects after 
48 hours with different concentration treatments (Figure 2.1). DMSO expressed the 
highest toxic effect. The percentage of cell survival was under 80% with 1% DMSO 
treatment. Therefore, DMSO could not be used as solvent to dissolve the organic 
extract. Methanol did not affect the cell viability even though 8% of methanol was 
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used. For ethanol, below 3% of it would not cause any toxic effect. In short, methanol 
was a good solvent to dissolve the organic extract. However, ethanol could also be 
used as a solvent but it should be lower than 3%. 
All aqueous extracts exhibited the similar toxic effect (Figure 2.2). The cell 
viability was measured after 48 hours treatments by extracts with concentrations 
varying from 100)ig/ml to SOO^ ig/ml. The toxicity of aqueous extracts increased as the 
concentration increased. Since we want to estimate the anti-HBV effects of aqueous 
extracts on Alexander cells, the extracts could not cause any toxic effect after 
treatments. From the results (Figure 2.2), all aqueous extracts did not exhibit the toxic 
effect below 300|ig/ml treatments. Therefore, the aqueous extract concentration below 
300jig/ml was recommended for 48 hours treatment in further experiments. 
Organic extracts exhibited higher toxic effect than aqueous extracts (Figure 2.3). 
P. urinaria from Guangdong and P. virgatus from Hainan had higher toxic effect than 
P. pendulus from India when the extracts with concentration higher than 600|^ g/ml 
were used. For 48 hours treatment, the organic extract below 200|ag/ml was 
recommended. 
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Figure 2.1: Toxic effect of three solvents measured by M T T assay. The cells were 
treated by different concentrations of solvents for 48 hours. • : DMSO. • : 
Methanol. •: Ethanol. The data were expressed in mean 士 SD. 
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Figure 2.2: Toxic effect of three aqueous extracts measured by M T T assay. The cells 
were treated by different concentrations of extracts for 48 hours. • G D AE 
represents aqueous extract of P. urinaria from Guangdong. • H N AE represents the 
aqueous extract of P. virgatus from Hainan. • IN AE represents the aqueous extract 
of P. pendulus from India. The data were expressed in mean 士 SD. 
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Figure 2.3: Toxic effect of three organic extracts measured by M T T assay. The cells 
were treated by different concentrations of extracts for 48 hours. • G D OE 
represents organic extract of P. urinaria from Guangdong. • H N OE represents the 
organic extract of P. virgatus from Hainan. • IN OE represents the organic extract 
of P. pendulus from India. The data were expressed in mean 士 SD. 
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2.3.2 Effects on HBsAg Secretion and Viral Gene Expression 
To compare the effectiveness of aqueous and organic extracts of three 
Phyllanthus species on anti-HBV, the HBsAg secretion into medium and viral gene 
expression of Alexander cells were analyzed after treatments. 
The culture medium was collected for IMx assay after treatment. If the extract 
suppressed the viral gene expression, the production of viral proteins and the secretion 
of viral proteins into medium should be decreased. 
The effects on HBsAg secretion into medium after aqueous and organic extracts 
treatments of three Phyllanthus species were compared with control (without 
treatment) in Figure 2.4. All aqueous extracts decreased the HBsAg secretion. 
However, all organic extracts increased the HBsAg secretion. The aqueous and 
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Figure 2.4: The effect of aqueous and organic extracts of three Phyllanthus species on 
HBsAg secretion into medium after 48 hours treatments. IMx assay was performed. 
Control meant without treatment. The concentration of aqueous extract and organic 
extract were 300jig/ml and 150|ig/ml respectively. The higher absorbance value 
represents the higher amount of HBsAg released. The data were expressed in mean 士 
SD. 
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After the treatments of aqueous and organic extracts for 48 hours, the R N A was 
isolated and then converted to cDNA for semi-quantitative PGR in order to estimate 
the effects on gene expressions. (3-actin was used to confirm the R N A normalization. 
Pre S and S genes of HBsAg were selected for estimation the viral gene expressions. 
Primer sequences are shown in Table 2.1. The primer sequences of Pre S and S genes 
were synthesized according to Gerken et al (1991). All aqueous extracts suppressed 
the Pre S and S gene expressions. P. pendulus from India showed the most significant 
effect. P. urinaria from Guangdong caused better suppressive effect than P. virgatus 
from Hainan. The organic extracts of P. pendulus from India also suppressed the viral 
gene expressions most significantly. However, the organic extract of P. virgatus from 
Hainan exhibited better effect than P. urinaria from Guangdong. 
It was found that all of the organic extracts exhibited the contradictory effects on 
the cells. They suppressed the viral gene expressions in cells. However, they enhanced 
the HBsAg secretion in the culture medium. 
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Primers Sequences Length (bp) 
PreS forward 5,-GGGTCACCATATTCTTGG-3, 553 
reverse 5'-GTCCTAGGAATCCTGATG-3 ’ 553 
S forward 5,-GGATTGGGGACCCTGCGC-3, 625 
reverse 5 ’-CCCAATACCACATCATCC-3, 625 
P-actin forward 5'-AACTGGGACGACATGGAGAA-3’ 〜390 
reverse [5 '-CGGTGGTGGTGAAGCTGTA-3 ‘ 〜390 
Table 2.1: Primers used for semi-quantitative PGR. Their sequences and amplified 
length are shown. The primer sequences of Pre S and S genes are according to Gerken 
et al in 1991. 
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Figure 2.5: Comparison the effects on viral gene expressions of aqueous and organic 
extracts of three Phyllanthus species by semi-quantitative PGR. The p-actin was used 
as house keeping gene. Pre S and S were the genes for HBsAg. 1: control. 2: 
300|j,g/ml aqueous extract of P. urinaria from Guangdong. 3: 300jLig/ml aqueous 
extract of P. virgatus from Hainan. 4: 300ng/ml aqueous extract of P. pendulus from 
India. 5: 150|jg/nil organic extract of P. urinaria from Guangdong. 6: 150|Lig/ml 
organic extract of P. virgatus from Hainan. 7: 150|ag/ml organic extract of P. pendulus 
from India. The bar chart showed the band intensity measured by densitometer. 
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In order to analyze the above-mentioned contradictory effects of organic extracts 
six days treatments were performed. The organic extract of P. urinaria from 
I 
Guangdong and P. pendulus from India were selected for analysis. For six days 
experiment, the culture medium was replaced every two days and R N A samples were 
collected at day 2, day 4 and day 6. 
By comparing the result of HBsAg secretion in the culture media of Alexander 
cells with treatment and control without treatment (Figure 2.6), the organic extract of 
P. urinaria from Guangdong was found to enhance the HBsAg secretion at day 2. 
Afterwards, the HBsAg secretion was inhibited at day 4 and day 6. The organic 
extract of P. pendulus from India showed similar results (Figure 2.8). It enhanced the 
HBsAg secretion at day 2 and then decreased the HBsAg at day 4 and day 6. 
For studying their effects on viral gene expressions, control without treatment 
was used for comparison. Both control groups showed that the Pre S and S genes 
expressions increased continuously from day 2 to day 6 (Figure 2.7 and 2.9). The 
organic extract of P, urinaria from Guangdong did not affect the viral gene 
expressions significantly at day 2. However, its suppressive effects on Pre S and S 
genes were effective at day 4 and day 6 (figure 2.7). The organic extract of P. 
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pendulus from India dramatically decreased the viral gene expressions from day 2 to 
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Figure 2.6: Effect on HBsAg secretion of six days treatment organic extract of R 
urinaria from Guangdong. The cells were treated by 100)ig/ml of organic extract. The 
culture medium was collected at day 2, day 4 and day 6. Control meant without 
treatment. HBsAg was measured by IMX assay. 
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Figure 2.7: Semi-quantitative PCR of Pre S and S gene expression after six days 
treatments of organic extract of P. urinaria from Guangdong. The bar chart showed 
the band intensity measured by densitometer. The p-actin was used as house keeping 
gene. Control meant without treatment. 1: Day2 control. 2: Day4 control. 3: Day6 
control. 4: Day2 100)ig/ml organic extract of P. urinaria from Guangdong. 5: Day4 
100|jg/ml organic extract of P. urinaria from Guangdong. 6: Day6 lOO^ ig/ml organic 
extract of P. urinaria from Guangdong. 
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Figure 2.8: Effect on HBsAg secretion of six days treatment organic extract of/! 
pendulus from India. The cells were treated by lOO^ ig/ml of organic extract. The 
culture medium was collected at day 2, day 4 and day 6. Control meant without 
treatment. HBsAg was measured by IMX assay. 
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Figure 2.9: Semi-quantitative PGR of Pre S and S gene expression after six days 
treatments of organic extract of P. pendulus from India. The P-actin was used as house 
keeping gene. The bar chart showed the band intensity measured by densitometer. 
Control meant without treatment. 1: Day2 control. 2: Day4 control. 3: Day6 control. 4: 
Day2 100|ag/ml organic extract of P. pendulus from India. 5: Day4 100|ig/ml organic 
extract of P pendulus from India. 6: Day6 100)jg/ml organic extract of P. pendulus 
from India. 
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Aqueous and organic extracts of P. pendulus from India showed the most 
significant effect on suppression of viral gene expressions. Therefore, their effects on 
different concentration treatments were also studied. After 48 hour treatments, it was 
found that the inhibition of HBsAg secretion of aqueous extracts was dose dependent 
from 100|ig/ml to 300ug/ml. The organic extracts also enhanced the HBsAg secretion 
into medium at a dose dependent manner from 50|ig/ml to ISO^ ig/ml (Figure 2.10). 
On Pre S and S gene expressions, the aqueous extracts exhibited the dose dependent 
inhibition. However, the suppressive effects of 50|ig/ml, lOOug/ml and 150ug/ml of 
organic extract treatments were similar. 
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Figure 2.10: IMx assay of different concentrations of aqueous and organic extracts of 
P. pendulus from India after 48 hours treatment. Control meant without treatment. The 
concentration of aqueous extract was from 100|ig/ml to 300|ig/mL The concentration 
of organic extract was from 50)ig/ml to 150|ig/ml. 
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Figure 2.11: Semi-quantitative PCR of aqueous and organic extracts of P. pendulus 
from India after 48 hours treatment. 1: control without treatment. 2: 300|ig/ml 
aqueous extract. 3: 200|ag/ml aqueous extract. 4: 100|^ g/ml aqueous extract. 5: 
150)^ g/ml organic extract. 6: 100|ag/ml organic extract. 7: 50|ag/ml organic extract. 
The bar chart showed the band intensity measured by densitometer. The p-actin was 
used as house keeping gene. 
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2.3.2 Analysis of Intracellular Viral Proteins 
The Alexander cell line produces HBsAg in 22-nm particles of the same buoyant 
density as those found in the serum of infected patients (Marion et al” 1979). The 
major polypeptides of serum-derived HBsAg particles (p20, p23 and p25) were found 
in the particles from this cell line. The other three minor polypeptides (p31, p36 and 
p43) were also detected by immunoprecipitation with anti-HBs (Marion et al., 1979; 
Qu and Rutter, 1985). 
Two antibodies were used to recognize the intracellular HBsAg. Anti-receptor 
binding fragment (Pre S) antibody was purchased from Biogenesis. Since only large 
hepatitis B surface (LHBs) protein involves in the binding to the putative cellular 
receptor (Le Seyec et al., 1999), this antibody can only recognize LHBs (p43 
polypetide). The second antibody was anti-HBsAg. It was bought from Zymed 
Laboratories. 
The total cell lysate was obtained after the cells were lysed by lysis buffer. Half 
of the total cell lysate was subjected to centrifugation to separate the cell debris from 
soluble protein. Finally total cell lysate, soluble lysate and cell debris were obtained 
for Western blot analysis. From the result of Western blot analyzed by anti-HBs Ag 
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antibody, the p25 and p36 polypeptides were observed in cell lysate, soluble lysate 
and cell debris (Figure 2.12). The anti-Pre S antibody could only recognize p43 
polypeptide. This result showed that only total cell lysate and cell debris contained the 
p43 polypeptide (Figure 2.12). P43 polypeptide was not present in the soluble lysate. 
Therefore, total cell lysate was better used for Western blot analysis thus effect on all 
intracellular proteins could be examined. 
1 2 3 
P43 + ) g i i M l l 、 A n t i - P r e s 
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Figure 2.12: Comparison of the polypeptides of HBsAg from total cell lysate, soluble 
lysate and cell debris from Alexander cells. The surface proteins were determined by 
anti-Pre S and anti-HBsAg antibodies. Anti-Pre S antibody was specific for p43 
polypeptide. P25 and p36 polypeptides were recognized by anti-HBsAg antibody. 
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The protein samples were collected from cells after 48 hours treatments of 
aqueous and organic extracts of three Phyllanthus species. The anti-P actin was used 
to confirm the protein normalization done by Bradford assay. By comparing with 
control without treatment, the organic extract of three Phyllanthus species 
significantly decreased the amount of p43 HBsAg polypeptide (Figure 2.14). The 
aqueous extracts did not show this effect. Both aqueous and organic extracts of 
Phllanthus species did not affect other HBsAg polypeptides i.e. p25 and p36. 
As only organic extracts affected the p43 polypeptide, the effect of different 
concentrations of organic extract on intracellular HBsAg was also studied. 150jLig/ml, 
100|ig/ml and 50|jg/ml of organic extracts of P. urinaria from Guangdong were used 
to treat the cells for 48 hours. The Western blot results showed that the organic extract 
of P. urinaria from Guangdong only decrease the p43 polypeptide in dose dependent 
manner. The other HBsAg polypeptides were not affected (Figure 2.15). 
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Figure 2.13: Effect of aqueous and organic extracts of three Phyllanhus species on 
intracellular HBsAg polypeptides after 48 hours treatments. Anti-actin antibody was 
used to confirm the normalization of protein. The surface proteins were determined by 
anti-Pre S and anti-HBsAg antibodies. 1: control. 2: 300|Lig/ml aqueous extract of P. 
urinaria from Guangdong. 3: 300|ag/ml aqueous extract of P. virgatus from Hainan. 4: 
150)ag/ml organic extract of P. urinaria from Guangdong. 5: ISOjag/ml organic extract 
of P. virgatus from Hainan. 6: control. 7: 300|ig/ml aqueous extract of P. pendulus 
from India. 8: 150|ig/ml organic extract of P. pendulus from India. 
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Figure 2.14: Effect of different concentrations of organic extract of R urinaria from 
Guangdong on intracellular HBsAg polypeptides after 48 hours treatments. 1: control 
without treatment. 2: 150jig/ml organic extract. 3: lOOjig/ml organic extract. 4: 
50)ig/ml organic extract. 
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2.4 Discussion 
P. amarus is one of the most common and effective Phyllanthus species used to 
study anti-HBV (Calixto et al., 1998 and UxiQO et al., 1988). Other three Phyllanthus 
species were used in this study to compare their anti-HBV effects in vitro. Two of the 
species were collected from China. They were P. urinaria from Guangdong and P. 
virgatus from Hainan. One of the species, R pendulus, was from India. 
The human hepatoma cell line, Alexander cell line, has an epithelial morphology 
and secretes proteins characteristic of differentiated liver cells, but this cell line does 
not produce H B V virion and other viral protein except HBsAg (Aden et al., 1979 and 
Knowles et al., 1980). This cell line has been used to estimate the anti-HBV drug 
effectiveness by measuring HBsAg secretion into medium (Ji et al., 1993; Jayaram 
and Thyagarajan, 1996). Besides the effect on HBsAg secretion, the effect of herbal 
extracts on HBsAg gene expressions and intracellular HBsAg contents in this cell line 
were also estimated. 
From the results of toxicity test, methanol did not cause the toxic effect even 
though at 8% (figure 2.1). Therefore, it was selected for the solvent to dissolve 
organic extract of the herbs. The toxicity test of aqueous and organic extracts of three 
species were performed in order to find out the highest extract concentration that 
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would not lead to cytotoxic effect to the cells. All aqueous and organic extracts below 
300|ig/ml and 200|ig/ml respectively would not lead to cytotoxic effect (Figure 2.2 
/ 
and 2.3). 
IMx assay was performed to estimate HBsAg secretion into medium. All aqueous 
extracts decreased the HBsAg secretion but organic extracts increased the HBsAg 
secretion (Figure 2.4). Both extracts suppressed the Pre S and S gene expressions 
(Figure2.5). Why there were contradictory results of organic extracts? Since organic 
extracts suppressed the Pre S and S gene expressions, the viral proteins produced 
should also be decreased. Therefore, organic extract may enhance the secretion of 
intracellular HBsAg that accumulated in the cells. 
The immunnohistochemical studies indicated that intracellular HBsAg is 
accumulated in the cytoplasm and on the surface membrane of Alexander cells 
(Daemer et al., 1980; Gerber et al., 1981; Wen et al., 1981). Western blot analysis 
showed that the intracellular p43 LHBs polypeptide was significantly decreased after 
organic extract treatments (Figure 2.13). The effect was in dose dependent manner 
(Figure 2.14). Aqueous extracts did not exhibit any effect on this. Therefore, the 
enhancement of HBsAg secretion may be due to the action of organic extracts that 
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promoted the release of p43 LHBs polypeptide which already accumulated in the 
cells. 
For further confirmation, six-days cell incubation experiment for organic extracts 
of urinaria from Guangdong and P. pendulus from India was performed (Figure 2.9 
and 2.11). Since the viral gene expressions were continuously decreased as the days of 
treatments increased, the newly synthesized HBsAg was decreasing. Organic extracts 
promoted the HBsAg secretion at day two. According to the above hypothesis that 
organic extracts caused the accumulated p43 polypeptide release from Alexander cells, 
the phenomenon of enhancement of HBsAg secretion should be dismissed when all of 
the accumulated p43 polypeptide was secreted out. Afterwards, organic extracts 
should decrease the HBsAg secretion due to the effect they exert on viral gene 
suppressions. The IMx results showed in Figure 2.6 and 2.8 demonstrated the organic 
extracts of P. urinaria and P. pendulus inhibited the HBsAg secretion at day 4 and day 
6. Therefore, the false negative result on HBsAg secretion of organic extracts was 
only a transient effect. The extracts eventually inhibited the HBsAg secretion. The 
transient promotion of HBsAg caused by organic extracts in Alexander cells gave us 
more confidence to support the hypothesis that enhancement of HBsAg secretion was 
due to the release of intracellular p43 polypeptide. However, there was not enough 
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evidence to illustrate the exact mechanism of transient enhanced effect of HBsAg 
secretion done by organic extracts. 
P43 polypeptide belongs to LHBs protein (Le Seyec et al., 1998). Western blot 
analysis found that this polypeptide is only present in cell debris instead of soluble 
lysate. Cell debris includes the transmembane proteins (Figure 2.12). The 
immunnohistochemical studies also showed that intracellular HBsAg is located on the 
surface membrane of Alexander cells (Gerber et al., 1981). The demission of 
intracellular p43 LHBs polypeptide by organic extract may resolve the problem of 
LHBs protein accumulation in infected hepatocytes (Figure 2.13). Deregulated 
overproduction of the LHBs polypeptide in infected hepatocytes causes excess LHBs 
protein accumulates and cannot be secreted (Huang and Yen, 1993). Excess LHBs 
protein accumulated hepatocytes were found to be exquisitely sensitive to the 
cytopathic effect of interferon gamma (Gilles et al., 1992). Accumulation at very high 
concentration of this protein may eventually cause death of the cells (Chisari et al., 
1987). 
All aqueous and organic extracts exhibited the anti-HBV effects by suppression 
of Pre S and S gene expressions. Both extracts of P. pendulus from India showed the 
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most significant effect. The aqueous and organic extracts of P. urinaria from 
Guangdong and P. virgatus from Hainan performed similar effectiveness, but they are 
less effective than P. pendulus from India. The organic extracts of three Phyllanthus 
species dramatically decreased the intracellular p43 polypeptide after 48 hours 
treatments. They had similar effectiveness base on this criterion. 
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CHAPTER 3 ISOLATION AND CHARACTERIZATION OF ACTIVE 
COMPONIENT FROM AN ORGANIC EXTRACT OF PHYLLANTHUS 
URINARIA (GUANGDONG) 
3.1 Introduction 
Even though there were many studies supporting the beneficial effects of 
Phyllanthus species against HBV, the active component(s) responsible for anti-HBV 
is(are) still unknown. Therefore, one of the objectives was the isolation of the active 
component from Phyllanthus species. Despites suppression Pre S and S gene 
expressions, organic extract had the transient effect on HBsAg secretion that may be 
due to promoting of the secretion the intracellular p43 LHBs polypeptide (Figure 
2.13). The decrease of intracellular p43 LHBs polypeptide may resolve the problem of 
LHBs protein accumulation in the infected hepatocytes. Since the organic extract 
seems potentially to be more active as an anti-HBV drug, R urinaria from Guangdong 
was used for further purification of its active component from organic extract. 
The bioassay for screening the active component was based on suppression of 
viral gene expressions. 
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3.2 Materials and Methods 
3.2.1 Materials 




Ethyl acetate B D H Laboratory Suppliers 
Hexane Merck 
N-butanol Merck 
Silica gel 60 Merck 
Vanillin Merck 
Instruments 
Fraction collector Bio-Rad 
Rotory evaporator Buchi 
Spectophotometer Bechman 
TLC aluminium sheet Merck 
The other chemicals, antibodies and instruments were shown in the section of 
Materials and Methods in Chapter one. 
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3.2.2 Methods 
3.2.2.1 Ethanol Extraction 
One kg of P urinaria from Guangdong was refluxed with 95% ethanol (EtOH) 
for 2 hours, for two times (4.5 L and 4 L respectively). The ethanol extracts were 
combined and left overnight at room temperature. After filtration, the filtrate was 
evaporated to dryness under reduced pressure at 40 ^ C to give the 95% EtOH extract 
(syrup). 
3.2.2.2 Partitions 
The 95% EtOH extract was partitioned between 500ml chloroform (CH3CI) and 
500ml water (H2O). The CH3CI phase was evaporated to dryness and partitioned 
between 500ml hexane and 500ml methanol (MeOH). After evaporation, two 
fractions were obtained, i.e. hexane extract (lOg, Fraction A) and M e O H extract 
(11.8g, Fraction B). The 300ml H2O phase was extract with 200ml n-butanol 
(n-BuOH) for two times (300ml and 200ml respectively). N-BuOH solution was 
evaporated to dryness to give an n-BuOH extract (28 g, Fraction C). The final H2O 
phase offered a light yellow H2O extract (29 g, Fraction D). 
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3.2.2.3 Column Purification 
The effective fraction was further separated by silica gel (70-230 mesh) column 
chromatography and eluted with discontinuous gradient solvents. For the first trial of 
column chromatography, the solvents were chloroform and methanol. Their 
combinations were 97:3, 94:6 and 90:10. For the second trial of column 
chromatography, ethyl acetate (EtoAC) and methanol were used. Their combinations 
were 100:0 and 90:10. The eluent was collected by a fraction collector. 
3.2.2.4 Analytical Thin Layer Chromatography (TLC) 
The eluent collected by fraction collector was monitored by Thin Layer 
Chromatography (TLC) and pooled into several fractions for assay. Silica gel 
precoated on an aluminum sheet was used for TLC. The TLC plate was sprayed with 
vanillin reagent. 
3.2.2.5 Crystallization 
The fraction with two spots was separated by the method of crystallization. The 
component of higher concentration in the fraction would be crystallized first. The 
crystallization was taken place in methanol and ether. The crystals were formed after 
overnight incubation of solvents. 
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The other methods were described in the section of Materials and Methods in Chapter 
one. 
3.3 Results 
3.3.1 Analysis of Four Fractions after Partitions 
The purification procedures were shown in Figure 3.1. The EtOH extract was 
obtained after refluxing 1kg of P. urinaria from Guangdong with ethanol. After 
partition of EtOH extract, four fractions were separated. lOg of hexane extract was 
named as Fraction A. 11.8g of methanol extract was named as Fraction B. 28g of 
n-butanol extract was named as Fraction C. Finally, 29g of water extract was named 
as Fraction D. 
These four fractions were subjected to study their anti-HBV effects. IMx assay 
showed that Fractions A and B enhanced the HBsAg secretion but Fraction C and D 
slightly decreased the HBsAg secretion (Figure 3.2). For screening the active fraction, 
semi-quantitative PCR was performed. Fraction B suppressed the Pre S and S gene 
expressions most significantly at the lowest concentration (Figure 3.3). Therefore, 
Fraction B was subjected to further purification. 
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Figure 3.2: IMx assay of four fractions separated by partitions of EtOH extract of P. 
urinaria from Guangdong. Control meant without treatment. The cells were treated by 
80)ig/ml of Fraction A, 40|Lig/ml of Fraction B, 150|Lig/ml of Fraction C and 150|ig/ml 
of Fraction D for 48 hours. 
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Figure 3.3: Screening the most active fraction from four fractions separated by 
partitions of EtOH extract of P. urinaria from Guangdong after 48 hours treatments. 1: 
control without treatment. 2: 80|^ g/ml Fraction A. 3: 40|Lig/ml Fraction B. 4: 150|ag/ml 
Fraction C. 5: ISO^ ig/ml Fraction D. The bar chart showed the band intensity 
measured by densitometer, p-actin was a house keeping gene for normalization. 
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3.3.2 Screening of the Active Fraction after Column Chromatography of 
Fraction B 
The Fraction B was further separated by silica gel column chromatography. The 
column was eluted with a discontinuous gradient solvent of chloroform and methanol 
(97:3, 94:6 and 90:10). The eluent was monitored by TLC with vanillin reagent 
staining. Finally, seven fractions were isolated. Their TLC profile was shown in 
Figure 3.4. 
For their effects on HBsAg secretion, 20|ig/ml of Fractions 1 to 5 of Fraction B 
just slightly promoted HBsAg secretion. The enhancements of HBsAg secretion of 
lOjj-g/ml Fraction 6 and 20)ig/ml Fraction 7 were higher than that of 40|ig/ml Fraction 
B (Figure 3.5). On their effect on Pre S and S gene suppressions, Fraction 6 
demonstrated the most significant effect. 10|Lig/ml of Fraction 6 expressed the similar 
suppressive effect as 40|ig/ml Fraction B (Figure 3.6). The active Fraction 6 (1.3g) 
was chosen for further purification. 
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Figure 3.4: TLC plate showed seven fractions separated from Fraction B by silica gel 
column chromatography. The solvents for running TLC were CH3CI and M e O H 
(95:5). The TLC plates were sprayed with vanillin reagent. A: Fraction B. B: Fraction 
1 (B-Fl). C: Fraction 2 (B-F2). D: Fraction 3 (B-:F3)。E: Fraction 4 (B-F4)。R 
Fraction 5 (B-F5). G: Fraction 6 (B-F6). 
! 
1000 - rn i 
_ n n I 
(U _ -o ____ 
运 门 门 门 
安 600 -O  
< 400 -
S 丨； 
200 - I 
J 
Q 11 I I I I I I I I I 1 I I J i 
control B 40ug/ml B-Fl B-F2 B-F3 B-F4 B-F5 B-F6 B-F7 
20ug/ml 20ug/ml 20ug/ml 20ug/ml 20ug/ml lOug/ml 20ug/ml 
Figure 3.5: IMx assay of seven fractions separated from Fraction B after 48 hours 
treatments. Control meant without treatment. AO\xglm\ Fraction B was used for 
comparison. The treatment concentration of all fractions was 20|ag/ml except Fraction 
6 which was lOng/ml. 
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Figure 3.6: Screening the most active fraction separated from Fraction B by column 
chromatography by semi-quantitative PCR. After 48 hours treatments, R N A was 
extracted for studying their effects on viral gene expressions. 1: control without 
treatment. 2: 40|ig/ml Fraction B. 3: 20)LXg/ml Fraction L 4: 20|ag/ml Fraction 2. 5: 
20^g/ml Fraction 3. 6: 20|ig/ml Fraction 4. 7: 20|ag/ml Fraction 5. 8: 10)ig/ml 
Fraction 6. 9: 20|ig/ml Fraction 7. p-actin was house keeping gene for normalization. 
The bar chart showed the band intensity measured by densitometer. 
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3.3.3 Screening of the Active Fraction after Column Chromatography of 
Fraction 6 
Ig of Fraction 6 was further purified by silica gel chromatography. The eluent 
buffer for column chromatography was a mixture of ethyl acetate and methanol 
(100:00 and 90:10). Eight fractions were collected from the separation. Their TLC 
chromatography profile was shown in Figure 3.7. 
From the result of IMx assay, the Fraction 6-7 and Fraction 6-8 promoted the 
HBsAg secretion higher than that of Fraction 6. Other fractions (Fraction 6-1 to 
Fraction 6-6) did not affect HBsAg secretion (Figure 3.8). The Fraction 6-7 also 
showed the highest suppressive effect on Pre S and S gene expressions (Figure 3.9). 
From the TLC profile (Figure 3.7), there were two green spots on Fraction 6-7. 
Therefore, further purification of Fraction 6-7 was done. 
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Figure 3.7: TLC plate showed eight fractions separated from Fraction 6 by silica gel 
column chromatography. The solvents for running TLC was EtoAc and M e O H (8:2). 
The TLC plates were sprayed with vanillin reagent. A: Fraction 6-1. B: Fraction 6-2. 
C: Fraction 6-3. D: Fraction 6-4. E: Fraction 6-5. F: Fraction 6-6. G: Fraction 6-7. H: 
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Figure 3.8: IMx assay of eight fractions separated from Fraction 6 after 48 hours 
treatments. Control meat without treatment. The treatment concentration for all 
fraction was lO^ ig/ml. 
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Figure 3.9: Screening the most active fraction separated from Fraction B by column 
chromatography. The assay was performed after 48 hour treatments. 1: control 
without treatment. 2: 10)ig/ml Fraction 6. 3: 10)ig/ml Fraction 6-1. 4: 10|Lig/ml 
Fraction 6-2. 5: 10|ig/ml Fraction 6-3. 6: lO^ ig/ml Fraction 6-4. 7: 10|ag/ml Fraction 
6-5. 8: lO^ ig/ml Fraction 6-6. 9: 10|ig/ml Fraction 6-7. 10: 10|Lig/ml Fraction 6-8. 
3-actin was house keeping gene for normalization. The bar chart showed the band 
intensity measured by densitometer. 
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3.3.4 Crystallization and Identification of the Isolated component 
Two green spots were observed from the TLC profile of Fraction 6-7 (Figure 3.6). 
Column chromatography was performed to separate these two components. However, 
this method could not separate these two components. This was because the polarities 
of these two components were similar. Therefore, the method of crystallization was 
used. By comparing their area of spots, the spot with higher polarity was in smaller 
amount. Theoretically, the larger amount component would be crystallized first. 
Therefore, the fraction of F6-7 was tried to crystallize with methanol and ether. A 
black-green solid was obtained. It was named as F6-7R The TLC result of F6-7P 
showed that there was only one spot which was the same as the large spot of F6-7 
(Figure 3.9). 20mg of F6-7P was isolated from 1kg of P. urinaria. Since the 
compound isolated was black-green in color. It may be related to chlorophyll. 
Therefore, its UV/Vis spectrum from wavelength 400nm to 700nm was measured and 
compared with that of chlorophyll a and chlorophyll b. After dissolving in ether, their 
absorbances were measured. Their maximum absorptions were shown in Table 3.1. 
The absorption profile of F6-7P was completely different from chlorophyll b. 
However, the maximum absorptions of F6-7P and chlorophyll a were little bit similar 
in some wavelengths. 
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For fiirther investigation of F6-7P, electrospray mass spectrometry was 
i 
performed. The result of high resolution FAB-MS spectrum showed that the 
molecular weight of F6-7 was 592.267129 (Figure 3.11). According to this molecular 
weight, the isolated active component was identified as pheophorbide a and its 
molecular formula is C35H36N4O5. UV/Vis spectrum of F6-7P had the maximum 
absorption at 666nm in methanol. 
Figure 3.10: TLC result of F6-7R F6-7P was crystallized from Fraction 6-7. Only one 
dark green spot was observed on the TLC plate. The solvent for TLC were ethyl 
acetate and hexane (8:2). 
Absorption max from 400nm to 700nm (ether) 
F6-7P 409, 474, 505, 536, 580，610, 667 
Chlorophyll a — 4 0 6 , 428, 530, 576, 614, 660 
Chlorophyll b 404, 415, 453，567, 594, 642 
Table 3.1: Comparison of the spectrum of F6-7P with chlorophyll a and chlorophyll b 
in ether. The maximum absorptions from wavelength 400nm to 700nm were shown. 
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Figure 3.11: Result of High resolution FAB-Mass Spectrometry. The molecular 
weight of F6-7P was 592.267129. 
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For structure determination, Nuclear Magnetic Resonance (NMR) of F6-7P was 
also done. The ^H N M R and ^ C^ N M R spectra were recorded on a 300MHz Bruker 
spectrometer in Acetone-De. The chemical shifts are reported in 5(ppm) with T M S as 
an internal standard and coupling constants (J) are give in Hz. 
The following was the result of ^ C^ N M R (Figure 3.12). ^^ C N M R (75.5 MHz, 
Acetone-d6, TMS, 6 ppm) 5: 9.1(C-7a), 9.9 (C-2a), 10.2(C-12a), 15.7 (C-8b), 17.6 
(C-8a), 21.5 (C-18a), 29.1 (C-17a), 29.4 (C-17b), 48.9 (C-18), 50.3 (C-13e), 51.0 
(C-17), 63.5 (C-13b), 92.6 (C-20), 95.9 (C-5), 103.3 (C-10), 103.3 (C-15), 121.2 
(C-3b), 121.2 (C-13), 127.8 (C-3a), 127.9 (C-12), 131.1 (C-2), 134.8 (C-3), 135.1 
(C-4), 135.1 (C-7), 135.1 (C-11), 140.8 (C-1), 144.1 (C-8), 149.8 (C-9), 152.2 (C-6), 
160.8 (C-14), 168.5 (C-16), 169.8.0 (C-19), 172.0 (C-13c), 172.3 (C-17c) and 188.1 
(C-13a). 
The following was the result of ^ H N M R (Figure 3.13). ^H N M R (300 MHz, 
Acetone-d6, TMS, 5 ppm) 6: 1.57 (3H，t,J=8，H-8b), 1.83(3H.d,J=7,H-18a),2.25 and 
2.34 (each 2H,m, H-17b and H-17a), 3.04 (3H,s,H-7a), 3.39(3H，s,H-2a), 
3.60(3H,s,H-12a), 3.87(3H,s,H-13e), 4.20 (lH,m,J=7,H-17), 4.64 (lH,m,J=7,H-18), 
6.12(lH,dd,J=2,ll,H-3bx), 6.27(lH,dd,J=2,18,H-3by), 6.34 (lH,s,H-13b)，8.02 
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(lH,ddJ=ll,18,H-3a), 8.84 (lH,s,H-20), 9.24 (lH，s,H-5) and 9.57 (lH,s,H-10). The 
1h N M R result of F6-7P was same as that reported for pheophorbide a ((Hynninen 
and Lotjonen, 1980) (Table 3.2). Therefore, F6-7P could be confirmed as 
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Figure 3.12: The ^ C^ Nuclear Magnetic Resonance (NMR) result of F6-7P. (75.5 MHz, 
Acetone-de, TMS, 6 ppm) 
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Figure 3.13: The ^ H Nuclear Magnetic Resonance (NMR) result of F6-7R (75.5 MHz, 
Acetone-de, TMS, 5 ppm) 
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H Pheophorbide a F67-P 
2a 3.04 (s,3H) 3.39 (s,3H)  
3a 8.04(dd,lH,J=ll,18) 8.02(dd,lH,JNll,18) 
6.28(dd，m,J=2,18) 6.27(dd, m,J=2,18) 
3b 6.13 (dd, 1H, J=2,11) 6.12(dd, 1H, J 二 2,11) 
5 9.29(s,lH,H-5) 9.24(s,lH)  
7a 3.07(s,3H) 3.04(s,3H)  
8a 3.55(q,2H,J-7) 3.57(q,2H,J=8)  
8b 1.59(t,3H,J=7) 1.57(t,3H,J=8)  
10 9.60(s,lH) 9.57(s,lH)  
12a 3.61(s,3H) 3.60(s,3H)  
13b 6.34(s,lH) 6.34(s,lH)  
13e 3.88(s,3H) 3.87(s,3H)  
17 4.20(m，lH,J=7) 4.20(m,lH,J-7)  
17a 2.46(m,2H) 2.25(m,2H)  
17b 2.46(m,2H) 2.34(m,2H)  
18 4.65(m,lH,J:7) 4.64(m,lH,J=7)  
18a 1.84(d,3H,J=7) 1.83(d,3H,J=7)  
20 8.86(s,lH) 8.84(s,lH)  
Table 3.2: Comparison the ^ H N M R result of F6-7P and pheophorbide a. The result of 
pheophorbide a was done by Hynninen and Lotjonen in 1980. 
89 
a ya 
^ N H 8b 
" C O O H " ^ C 0 0 C H 3 
Figure 3.14: The structure of pheophorbide a. 
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Figure 3.15: The structure of chlorophyll a and chlorophyll b (The Merck Index, 
1996). 
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3.3.5 Study the Anti-HBV Effects of Pheophorbide a 
The active component isolated (F6-7) was proven to be pheophorbide a. The 
cytotoxic effect of pheophorbide a was investigated first. Pheophorbide a from 
2.5)ag/ml to 20|ig/ml was used to treat the Alexander cells for 48hours. M T T assay 
was performed in order to calculate the percentage of cell survival after treatments. 
20)ig/ml of pheophorbide a expressed a little bit of cytotoxic effect. However, the cell 
viability was not affected under treatment concentrations at and below 10|ag/ml 
(Figure 3.16). For in vitro study of Alexander cells, the treated concentration of 
pheophorbide a should not be exceed lOjig/ml. 
The different concentrations of pheophorbide a were used to treat the Alexander 
cells for 48 hours. After treatments, the culture medium was collected for HBsAg 
assay and the R N A was extracted for Pre S and S gene expressions assay. IMx assay 
demonstrated that pheophorbide a enhanced the HBsAg secretion. The enhancement 
effects was dose dependent from 0.313f^ g/ml to 10)ig/ml of pheophorbide a. The 
HBsAg secretion promoted by lOug/ml of pheophorbide a was nearly a double to that 
of control without treatment (Figure 3.17). The Pre S and S gene suppressive effects 
of pheophorbide a showed dose dependently from 0.313|ig/ml to lOj^ ig/ml (Figure 
3.18). 
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Pheophorbide a , chlorophyll a and chlorophyll b are green in color. They have 
similar structure (Figure 3.13 and 3.14). The UV/Vis spectrum of pheophorbide a 
(F6-7P) was similar to chlorophyll a (Table 3.1). Therefore, chlorophyll a and 
chlorophyll b were also studied for their effect on Pre S and S gene expressions. IMx 
assay showed that 5|^ g/ml of chlorophyll a and chlorophyll b did not affect the HBsAg 
secretion of the cells after 48 hours treatments (Figure 3.18). From the result of 
semi-quantitative PCR, chlorophyll a and chlorophyll b also did not affect the Pre S 
and S gene expressions (Figure 3.19). 
92 
lOOfi -






OD ‘ ^ ‘ 
20ug/tal lOug 如 1 5ug 如 1 25ug 如 1 
Pheophorbide a 
Figure 3.16: M T T assay of pheophorbide a. The Alexander cells were treated by 
pheophorbide a for 48 hours from 2.5jig/ml to 20|ig/nil. The percentage of survival of 
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Figure 3.17: The IMx assay of pheophorbide a after 48 hours treatments. The 
concentrations of pheophorbide a were from 0.313|ig/ml to lO^ ig/ml. 
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the structure of F6-7P is identity to pheophorbide a. The ^ C^ N M R spectrum showed 
the presence of three carbonyl carbons at 5 188.1, 172.3 and belonged to an ester 
(CI3c) and an acid (C-17c). The N M R spectrum of F6-7P was same as that of 
pheophorbide a (Hynninen and Lotjonen, 1980). The structure of F6-7P 
(pheophorbide a) was shown in Figure 3.14. 
Pheophorbide a is a metal-free chlorophyll a derivative. Therefore, chlorophyll a 
and chlorophyll b were investigated for their effect on Alexander cells. Both 
chlorophylls did not affect the HBsAg secretion and viral gene expressions of the 
cells (Figure 3.19). Another artificial chlorophyll a derivative, sodium copper 
chlorophyllin was shown to have the anti-HBV effect (Wong, 1980; Yang et al., 1998; 
Feng, 2000). Sodium copper chlorophyllin had been used as a medicine in China for 
the treatment of hepatitis B (Wong, 1980). Pheophorbide a and sodium copper 
chlorophyllin have a similar structure (Figure 3.19). Being water-soluble is the 
advantage of sodium copper chlorophyllin. 
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Figure 3.21: The structures of sodium copper chlorophyllin (Adopt from Yang et al., 
1998) and pheophorbide a. A: Two-sodium salt of sodium copper chlorophyllin. B: 
Three-sodium salt sodium copper chlorophyllin. C: Pheophorbide a 
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The enhancement of HBsAg secretion and suppression of Pre S and S gene 
expressions of pheophorbide a was observed in a dose dependent manner. The HBsAg 
secretion promoted by lOug/ml of pheophorbide a was nearly a double to that of 
control without treatment. This enhancement effect was higher than that of 150)Lig/ml 
of organic extract of R urinaria from Guangdong, i.e. the starting purification sample. 
Moreover, the viral gene suppressive effect of lOug/ml pheophorbide a was also more 
effective than that of 150|Lig/ml of organic extract of P. urinaria. These finding 
implied that the active component of organic extract of P. urinaria had at least 
purified by 15 folds. 
Pheophorbide a had been isolated from another plants such as Neptunia oleracea 
and Solarium diflorum (Nakamura et al； 1996; Heinrich et al., 2001) and were shown 
to have anti-cancer effects (Tassetti et al., 1997; Hajri et al., 2002). However, there is 
no report of it related to the treatment of hepatitis B. It is the first discovery that 
pheophorbide a has anti-HBV effects in vitro. Besides the suppression the Pre S and S 
gene expressions efficiently, it also strongly promotes HBsAg secretion from the cells 
that may resolve the over expression of LHBs protein in infected hepatocytes. 
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CHAPTER 4 STUDY OF PRE S I PROMOTER ACTIVITY OF HBV 
4.1 Introduction 
The previous in vitro studies found that pheophorbide a isolated from the organic 
extract of P. urinaria and aqueous and organic extracts of three Phyllanthus species, 
down-regulated HBsAg m R N A transcription in Alexander cells. These findings raised 
the important questions concerning whether the extracts directly regulated H B V 
promoter or this down-regulation was an indirect effect. 
There are four defined overlapping open reading frames (ORFs) in the H B V 
genome which result in the transcription and expression of the seven different 
hepatitis B proteins (Ganem and Varmus, 1987). ORF P occupies the majority of the 
genome and encodes for the hepatitis B polymerase protein. ORF S encodes the three 
surface proteins (Heermann et al, 1984). ORJF C encodes both the hepatitis e and core 
protein. ORF X encodes the hepatitis B X protein. The four ORFs lead to the 
transcription and translation of seven different H B V proteins through the use of 
varying in-frame start codons (Figure 4.1). The four ORFs transcription are controlled 
by four promoter elements (preSl, preS2, core and X), and two enhancer elements 
(Enh I and Enh 11) (Tiollais et al., 1985). 
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Figure 4.1: The hepatitis B viral genome. The viral genome is numbered (0-3200bp) 
according to the adw! subtype of HBV. S, C, P, and X represent the viral genes 
encoding the surface antigen, core/e antigen, polymerase, and X proteins respectively. 
The H B V promoters (preSl, preS2, Cp and Xp) and enhancers (Enhl and Enh2) are 
indicated (Adopted from Kosovsky and Siddiqui, 1999). 
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ORF S contains three in-frame start sites that direct synthesis of the three distinct 
hepatitis B surface proteins (Enble et al, 1986). There are two promoter regions that 
control the expression of these proteins, namely the Pre SI promoter and Pre S2 
promoter. The Pre S1 promoter (TATA-containing promoter) controls transcription of 
a single R N A molecule which codes for the large surface antigen (Heermann et al, 
1984). However, the Pre S2 promoter (TATA-less promoter) gives rise to several 
heterogeneous R N A species that code for both the middle surface and major surface 
antigens (Siddiqui et al, 1986). 
Transcription from Pre SI promoter but not for Pre S2 promoter shows 
hepatocyte specificity in transient transfection assays (Chang and Ting, 1989). This 
cell type specificity is believed to account partially for the hepatotropism of H B V and 
has been attributed to the presence of liver-specific transcription factors such as 
HNF-1 and HNF-3 (Chang et al, 1989; Raney et al., 1990; Zhou and Yen, 1991). 
H B V enhancer elements also appear to be involved in Pre S1 promoter up regulation 
(Yuh and Ting, 1990). The Pre S2 promoter has been shown to be stronger than the 
Pre SI promoter (Raney et al., 1989). Therefore, more middle and small surface 
proteins are expressed as compared to the large surface protein. However, over 
expression of the large surface protein results in retention of surface proteins in the 
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endoplasmic reticulum which is a common feature of infected hepatocyte (Persing et 
al” 1986; Huang and Yen, 1993). ‘ 
R amarus was found to decrease the HBsAg m R N A transcription in vitro and in 
vivo. Analysis in HuH-7 cells (human hepatocellular carcinoma) with transfected 
plasmids using a luciferase reporter showed that P. amarus specifically inhibited H B V 
enhancer I and Pre S I activity. To further identify the mechanism of H B V inhibition, 
P. amarus was proven to inhibit C/EBPa- and C/EBPp-mediated up regulation of 
H B V enhancer I activity in a dose dependent manner (OTT et al, 1997). 
The human hepatoma Alexander cell line contains at least seven copies of H B V 
D N A integrated in its genome. However, this cell line selectively expresses the 
HBsAg gene. The disruption of H B V genome during integration causes the integrated 
clones miss one or other of the regulatory elements (Ou and Rutter, 1985). The 
deregulation of surface proteins in infected hepatocytes was found to be related to the 
disruption of H B V genome during integration (Huang and Yen, 1993). This may be 
due to a strong exogenous promoter element inserted upstream of the HBsAg region 
(Chisari et al, 1987). 
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Pheophorbide a, aqueous and organic extracts of three Phyllanthus species 
suppressed the HBsAg gene expression of Alexander cells. In order to estimate 
whether they regulated the H B V promoter or this was indirect effect, the Pre SI 
promoter was cloned and the effect of extracts on its activity was be studied. 
107 
4.2 Materials and Methods 
4.2.1 Materials 
Chemicals 
QIAEX II Agarose Gel Extraction Protocol QIAGEN 
Calcium chloride U S B 
dTTP Fermentus 
Dual-Luciferase® Reporter Assay Kit Promega 
Glycerol USB 
H B V in pUC18 ATCC 
IPTG Fermentus 
LB broth U S B 
LIPOFECTAMINE p l u s ™ Reagent Invitrogen 
Mangansis chloride Sigma 
M O P S Sigma 
Platinum Pfx D N A Polymerase Invitrogen 
pBluescript Stratagene 
pGL3 basic Promega 
pGL3 control Promega 
Potassium acetate Sigma 
Primers Invitrogen 
pRL-CMV vector Promega 
Rapid Plasmid Miniprep Kit Invitrogen 
Restriction enzymes Fermentus 
Rubidium chloride USB 
RPMI medium 1640 Invitrogen 
Sodium acetate Sigma 




Bacterial incubator Sanyo 
Luminometer Gemini 
Orbital incubator Gallenkamp 
The other chemicals and instruments were shown in the section of Materials and 
Methods in Chapter one and two. 
4.2.2 Methods 
4.2.2.1 Cell line 
The human hepatoma Hep 3B2.1-7 (Hep3B) cell line purchased from 
American Type Culture Collection (ATCC) was cultured in RPMI medium 1640 
supplemented IX Penicillin-Streptomycin-Neomycin (PSN) antibiotic and 10% fetal 
bovine serum in a 37°C humidified 5 % incubator. 
4.2.2.2 Cloning of Pre SI Promoter from HBV Genome 
A pair of primers with restriction enzyme digestion site were designed to amplify 
the Pre SI promoter. Kpn I and Xho I cutting sites were added to forward and reverse 
primer respectively. H B V genome in pUC 18 was used as template. The Pre SI 
promoter was amplified by polymerase chain reaction (PCR) using corresponding 
primers. PLATINUM® Pfx D N A polymerase with proofreading was applied for this 
PCR reaction. Amplification was carried out using GeneAmp® PCR System 9700 in 
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Figure 4.4: 1% agarose gel electrophoresis showed the releasing of 431 bp Pre SI 
promoter from the pBluescript® II KS (-) after digestions of Kpn I and Xho I. lOObp 
marker was used. 
M 1 2 
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Figure 4.5: Further confirmation the subclonning of Pre SI promoter to pGL3 basic 
vector. 1% agarose gel electrophoresis was performed after double digestion of vector 
by Kpn I dindXho I. 1: Pre SI promoter in pGL3 basic vector. 2: pGL3 basic (negative 
control). Lane 1 showed that 431 bp Pre SI promoter was released from Kpn I ^ndXho 
I cut pGL3 basic vector. lOObp marker was used. 
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4.3.2 Sequences of the Pre S I Promoter 
The plasmid of Pre SI promoter in pBluescript® II KS (-) was subjected to 
sequence analysis of its insert by using T7 promoter primer. The sequence of the T7 
promoter was 5'- TAA TAC GAC TCA CTA TAG GG -3'. The Pre SI promoter was 
shown in figure 4.6. The computer analysis by BLAST showed that this Pre SI 
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Figure 4.6: The sequence of Pre SI promoter. Pre S SI promoter was cloned in 
pBluescript® II KS (-) and sequenced by using T7 promoter primer. The primer 
sequences were underlined. Kpn I cutting site was at 5' end. Xho I cutting site was at 
3'end. 
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4.3.3 Pre S I Promoter Activities in Hep 3B Cell Line 
For promoter analysis, the pGL3 control vector was used as the positive control. 
This vector contains SV40 promoter and enhancer sequences, resulting in strong 
expression of firefly luciferase in many types of mammalian cells. The pGL3 basic 
vector was used as a negative control since it lacks any eukaryotic enhancer and 
promoter. This feature also allows maximum flexibility in cloning putative regulatory 
sequences. Therefore, Pre SI promoter was subclone into the pGL3 basic vector. 
Expression of firefly luciferase activity in cells that transfected with this plasmid 
depends on insertion and proper orientation of a functional promoter upstream of luc+. 
The pRL-CMV vector was used as internal control to normalize the transfection 
efficiency. The pRL-CMV vector contains the C M V enhancer and early promoter 
elements to provide high-level expression of Renilla luciferase in co-transfected 
mammalian cells. Despites normalization of transfection efficiency, the 
co-transfection of pRL-CMV could reduce extraneous influences. 
Dual-Lucifemse® Reporter Assay System was used to measure the two reporter 
assays. In this assay, the activities of firefly and Renilla luciferases were measured 
sequentially from a single sample. The firefly luciferase reporter was measured first 
by adding Luciferase Assay Reagent II (LAR II) to generate a luminescent signal 
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lasting at least one minute. After quantifying the firefly luminescence, this reaction 
was quenched and the Renilla luciferase reaction is initiated simultaneously by adding 
Stop & Glo® Reagent to the same sample. Both assays can be completed in about 
several seconds using a luminometer. 
Three hepatoma cell lines, Hep 3B, Hep G2 and PLC/PRF/5, were used to 
transfect the Pre S1 promoter in pGL3 basic vector. Pre S1 promoter expressed the 
highest activity in Hep 3B. Therefore, this cell line was selected to study the activity 
of Pre S1 promoter. 
Pre SI promoter was reported to have low promoter activity. Therefore, PreSl 
promoter in pGL3 basic vector was co-transfected with pRL-CMV vector in a 20 to 1 
ratio thus it could prevent the competition of endogenesis with a strong C M V 
promoter. By comparison the relative transcriptional efficacy of Pre S1 promoter and 
SV40 enhance and promoter in Hep 3B cells, pGL3 control vector with SV40 
enhancer and promoter had the highest luciferase activity. The luciferase activity of 
Pre S1 promoter in pGL3 basic vector was much lower than that of pGL3 control 
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Figure 4.7: Analysis of the relative transcriptional efficacy of the pGL3 basic, pGL3 
control and Pre SI promoter/ pGL3 basic in Hep 3B cells. The luciferase activity was 
most efficiency expressed by the pGL3 control plasmid, followed by the Pre SI 
promoter/pGL3 basic plasmid. The pGL3 basic vector devoid of any promoter 
showed no luciferase activity. 
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4.3.4 Effects of Herbal Extracts on Pre S I Promoter 
Pheophorbide a which was isolated from the EtOH extract of P. urinaria, 
together with aqueous and organic extracts of three Phyllanthus species, were used to 
study their effect on Pre SI promoter. For transient transfection assay, Pre SI 
promoter in pGL3 basic plasmid was transfected into Hep 3B cells for 24 hours before 
any treatment. The relative luciferase activity was calculated by firefly luciferase 
activity over Renilla luciferase activity. 
The transfected Hep 3B cells were incubated for 24 hours with medium 
containing aqueous extracts of three Phyllanthus species at 50|ig/ml and 25|ag/ml 
respectively. All aqueous extracts slightly inhibited the Pre SI promoter activity. The 
inhibitory effects of three Phyllanthus species were similar (figure 4.8). 
Organic extracts of three Phyllanthus species were also used to treat the 
transfected Hep 3B cells at 5 0 i J g / m l , 25|Lig/ml and 12.5|Lig/ml for 24 hours. Organic 
extracts showed the contradictory effect compared to that of aqueous extracts. They 
up-regulated the Pre SI promoter activity (Figure 4.9). The P. urinaria from 
Guangdong showed the maximum effect with this assay. Their up-regulation effects 
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were observed in a dose dependent manner. 
Pheophorbide a dose-dependently inhibited Pre SI promoter by up to 
approximately 50% of the control (Figure 4.10). Pheophorbide a from 0.125|Lig/nil to 
2fag/ml was applied to incubate the transfected Hep 3B cells for 24 hours. The down 
regulatory effect of Pheophorbide a was more significant than those of aqueous 
extracts. 
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Figure 4.8: Effect of aqueous extracts of three Phyllanthus species on Pre SI promoter 
activity. After transfection of Pre SI promoter in pGL3 basic vector for 24 hours, the 
transfected cells were treated by three aqueous extracts at 50jLig/ml and 25|ag/ml 
respectively for excessive 24 hours. G D A E represented aqueous extract ofR urinaria 
from Guangdong. H N A E represented the aqueous extract of P. virgatus from Hainan. 
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Figure 4.9: Regulation of Pre SI promoter activity by organic extracts of three 
Phyllanthus species. The transient transfected Pre SI promoter Hep 3B cells were 
treated by organic extracts at 50|Lig/ml, 25|ig/ml and 12.5|Lig/ml respectively for 24 
hours. Control meant without treatment. G D O E represented organic extract of P. 
urinaria from Guangdong. H N O E represented the organic extract of P. virgatus from 
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Figure 4.10: Dose-dependent down regulated of Pre SI promoter activity by 
pheophorbide a. After transfection of Pre SI promoter in pGL3 basic vector for 24 
hours, the transfected cells were treated by pheophorbide a from 0.125iLig/ml to 
2|ig/ml for 24 hours. The effect of pheophorbide a on Pre SI promoter was compared 
with that without treatment control. 
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4.4 Discussion 
The Pre SI promoter amplified from 3.2kb HBV genome in pUC18 was 
sub cloned into the pGL3 basic reporter vector for study of its promoter activity. The 
sequencing result of Pre SI promoter in pBluescript® n KS (-) further confirmed the 
promoter sequence after amplification. 
The human hepatoma Hep 3B cell line was used to estimate the Pre SI activity. 
This was because Pre SI promoter expressed higher activity in this cell line compared 
to Hep G2 and Alexander cells. Only hepatoma cell lines were used for transient 
transfection as Pre SI promoter show cell type specificity that is believed to be due to 
the presence of liver-specific transcription factors such as HNF-1 (Raney et al, 1990). 
LIPOFECTAMINE p l u s ™ Reagent was applied to transfect the plasmid into Hep 3B 
cells. LIPOFECTAMINE P L U S ™ Reagent itself is to cells. From our result, Hep 3B 
was sensitive to this reagent. Therefore, the transfected cells were grown up for 24 
hours before any treatment. This could allow the cells to recover and be more stable. 
Since after stress of transfection, the concentration of extracts used to treat the 
transfected Hep 3B cells should be lower than that used to treat the Alexander cells 
before. 
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PLC/PRF/5 is human hepatoma cell line integrated with H B V genome. During 
H B V genome integration into human genome, rearrangement of H B V genome may 
cause strong exogenous promoter element inserted upstream of HBsAg region 
(Chisari et al., 1987). Therefore, the viral gene suppressive effects of extracts may be 
caused by inhibition of human promoter upstream the HBsAg gene in Alexander cells 
or other indirectly pathways. The study of Pre SI promoter activity in transfected Hep 
3B cells allowed us to further understand whether the extract exerts the effect directly 
on H B V or through a indirect pathway. 
The data demonstrate that aqueous extracts of three Phyllanthus species slightly 
inhibited the Pre SI promoter activity. These inhibitory effects of three species were 
similar. The previous evidence of viral gene suppressive effects of aqueous extracts 
showed that P. pendulus from India had the most significant effect on this in 
Alexander cells. lOOug/ml of aqueous extract of/! pendulus down-regulated 50% of 
Pre S gene expression. However, P. pendulus from India did not have distinguished 
inhibitory effect on Pre SI promoter. Since two different cell lines were used for two 
different assays, so, transcription regulation may be different in these cell lines. 
Moreover, the effect of aqueous extract of P. pendulus from India on viral gene 
suppression may not be due only directly via the inhibition of viral promoter in 
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Alexander cells. 
The Pre SI promoter was up-regulated by organic extracts of three Phyllanthus 
species after 24 hours treatments. Their effects were dose dependent. Especially, the 
organic extract of P. urinaria from Guangdong demonstrated the most significant 
effect on this aspect. By comparing with their effect on Pre S gene suppression after 
48 hours treatments in Alexander cells, P. urinaria from Guangdong slightly 
promoted the Pre S gene expression, P. virgatus from Hainan it inhibited the Pre S 
gene expression slightly, P. pendulus from India had the maximum effect on Pre S 
gene suppression. Although P. urinaria slightly promoted the Pre S gene expression 
after two days treatment in Alexander cells, the Pre S gene expression was 
continuously decreasing as the day of treatment increased. The contradictory results 
of organic extracts on Pre S promoter activity and Pre S gene expression could be 
explained by several reasons. First, the Pre S gene suppressive effect of organic 
extracts in Alexander cells may not be due to direct inhibition on the Pre SI promoter; 
instead it might have been caused other by indirect pathways. Moreover, the crude 
organic extract contained many components that some may promote and others may 
suppress Pre S promoter. However, which component would act the significant effect 
on promoter may depend on the cell line used, time of treatment, cell sensitivity, the 
amount and potency of the various components, etc. 
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Pheophorbide a isolated from EtOH extracts of P. urinaria demonstrated a 
dose-dependent inhibition effect of Pre SI activity. 2|Lig/ml of it could suppress 50% 
of Pre SI promoter activity by comparing with control. This result showed that 
pheophorbide a could directly inhibit the Pre SI promoter activity effectively. 
Although pheophorbide a directly down-regulated the Pre SI promoter, the gene 
suppressive effect of it on Alexander cells may be due to direct inhibition on Pre SI 
promoter or / and through another indirect pathway. 
Pre SI promoter assay cannot completely reveal the mechanism of viral gene 
suppression in Alexander cells caused by Phyllanthus extracts. Instead, their effects 
on Pre SI promoter activity could show that their gene suppression effects were 
directly against HBV or not. Pheophorbide a had a significant effect on Pre S and S 
gene suppressions in Alexander cells. This result cannot directly be implicated to its 
effect on viral replication. This is because of the fact that Alexander cells do not 
support the HBV replication system. However, pheophorbide a inhibited the Pre SI 
promoter activity significantly, and thus it put the effort directly against HBV. This 
result lead to the significant implication that pheophorbide a may be a good potential 
drug against HBV as it can directly suppress viral gene expression through inhibition 
of viral promoter. 
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CHAPTER 5 GENERAL DISCUSSION 
Hepatitis B virus (HBV) infection is a world-wide public health problem. 
Chronic HBV infection causes serious liver disease in human, including chronic 
active hepatitis, cirrhosis, liver failure, primary hepatocellular carcinoma and 
superinfection with the hepatitis delta vims. Nowadays, no truly effective drug 
therapy against HBV has been developed. Moreover, drugs commonly used for the 
therapy for HBV cause side effects to patients. Therefore, it is urgent to develop a 
new effective drug without side effects for the therapy of hepatitis B. 
Natural product is one of the targets that researchers are interested to work on in 
order to develop a new therapeutic agent for hepatitis. Phyllanthus species have been 
used as a traditional treatment for jaundice and general liver problems from many 
years. In recent publications, many researches supported the effectiveness of 
Phyllanthus against HBV especially P. amarus (Clixto et cd,, 1998) 
In this project, the anti-HBV effects of three Phyllanthus species were studied 
and compared in vitro by using the Alexander cells. Besides, the active component 
from the organic extract of P. urinaria from Guangdong was isolated and 
characterized. Finally, their effects on Pre SI promoter have been be studied. 
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In the first part of research, three Phyllanthus species were collected for 
anti-HBV study. By comparing their effects on Pre S and S viral gene suppressions in 
Alexander cells, both aqueous and organic extracts of P. pendulus from India showed 
the most significant effect. The aqueous and organic extracts of P. urinaria from 
Guangdong and P. virgatus from Hainan had similar effect, but they are less effective 
than P. pendulus from India. From the results of IMx assay used to estimate HBsAg 
secretion into medium, all aqueous extracts decreased the HBsAg secretion indicating 
that the effect was due to the suppression of HBsAg gene expressions. However, 
organic extracts transiently increased the HBsAg secretion after 48 hours treatments. 
The elongation of the treatment time of organic extracts would reverse the 
enhancement effect to suppressive effect of HBsAg secretion. Since the intracellular 
p43 LHBS polypeptide was decreased after 48 hours treatments with organic extracts 
but it was not affected by aqueous extracts, the transient increase of HBsAg secretion 
from Alexander cells to medium may be due to the release of intracellular p43 LHBs 
polypeptide to medium. However, there was not enough evidence to illustrate the 
exact mechanism of transient enhanced effect of HBsAg secretion exert by organic 
extracts. In any case, the enhanced-release of intracellular p43 LHBs polypeptide by 
organic extract may resolve the problem of LHBs protein accumulation in infected 
hepatocytes. The mechanism of this effect would have to be studied for further 
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confirmation its validity. It is a concern that the transient enhancement of HBsAg 
secretion of organic extracts may give a false negative result with confusing levels of 
HBsAg in the content of patient / animal serum during the clinical / animal trial. 
However, the major markers represent H B V replication are HBeAg and H B V D N A . 
Since the in vivo result may not be same as the in vitro result, animal trial was 
recommended for organic extracts in order to investigate the detail mechanism in vivo 
before carry out any clinical trial. 
In the second part of isolation and characterization of active component from P. 
urinaria from Guangdong, partition, column chromatography and crystallization were 
used to isolate the active component, i.e. F6-7R The bioassay for screening the active 
component was based on the suppression of Pre S and S vial gene expressions in 
Alexander cells. For characterization ofF6-7P, FAB-Mass Spectrometry, ^ H N M R and 
13c N M R were performed. All the above results showed that F6-7P were identical to a 
derivative of chlorophyll a, namely pheophorbide a. Metal-free pheophorbide a, with 
molecular weight 592.3, was also studied for its anti-HBV effects in vitro by using 
Alexander cells. The enhancement of HBsAg secretion and suppression of Pre S and 
S gene expressions of pheophorbide a was in dose dependent manner and its effect 
was more effective than that of crude extract of P. urinaria from Guangdong. 
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Pheophorbide a, with strong suppressive effect on Pre S and S gene expression, seems 
to be a potentially promising compound for the therapy of HBV. However, fiirther 
experiments are needed to further confirm the effect and mechanism of pheophorbide 
a on H B V replication. 
Finally, the activity of Pre S promoter of H B V was studied. Since the 
suppression of Pre S and S gene expressions oiPhyllanthus extracts may be caused by 
inhibition of human promoter upstream the HBsAg gene in Alexander cells or other 
indirect pathways, the study of Pre SI promoter activity in transfected hepatoma cells 
allowed us to further understand whether the Phyllanthus extracts act directly on H B V 
or via an indirect pathway. The aqueous extracts of three Phyllanthus species slightly 
inhibited the Pre SI promoter activity. Their inhibitory effects of three species were 
similar. This result showed that aqueous extracts could directly inhibit Pre S gene 
expression. P. pendulus from India did not have the distinguish result on this aspect. 
This result was a little bit different from the significant effect of aqueous extract of P. 
pendulus from India on Pre S gene expression in Alexander cells. This may be due to 
the fact that two different cell lines were used for the two different assays; the 
transcription regulation may be different in these two cell lines. Moreover, the Pre S 
promoter activity was relatively low. Its activity could be increased by co-transfection 
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of cellular transcription factor (HNF-1). Higher magnitude of Pre S promoter activity 
would be beneficial for comparing the effect of extracts on it. The Pre SI promoter 
was up-regulated by organic extracts of three Phyllanthus species especially the 
organic extract of P. urinaria from Guangdong. However, the active component, 
pheophorbide a, isolated from P. urinaria from Guangdong demonstrated a 
dose-dependent inhibition effect on Pre SI activity. As crude organic extract 
contained many components, some of which may promote and others may suppress 
Pre S promoter. But, which component would exert the significant effect on promoter 
may depend on the cell line used, time of treatment, cell sensitivity, the amount and 
potency of various components, etc. Therefore, there was no doubt that the organic 
extracts may also contain other components that have an affect on the Pre S promoter. 
Pheophorbide a inhibited the Pre SI promoter activity significantly, and that meant it 
could exert the effect directly against HBV. For a more detail study on the Pre S 
promoter activity, co-transfection with cellular transcription factor such as HNF-1 is 
recommended. Co-transfection with transcription factor not only could increase the 
activity of promoter, but it also could study the combined effect on promoter and 
transcription factor together. 
In conclusion, the in vitro study of anti-HBV effects of three Phyllanthus species 
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by using Alexander cells gave us a roughly perspective by inspection of the effects of 
aqueous and organic extracts on anti-HBV. For a further study, these results will be 
useful references for further designing in vivo or clinical trial experiments. The 
species P. pendulus from India was strongly recommended for in vivo and clinical 
study. Since, Alexander cell line offer the first opportunity to study the formation of 
HBsAg at the molecular level in vitro, it provided a simple system for screening the 
active component. The compound isolated from organic extract of P. urinaria,, 
pheophorbide a, has been proven to have a similar structure as artificial sodium 
copper chlorophyllin which has been used as a medicine for hepatitis B therapy in 
China. The results of clinical trials in China supported the beneficial effect of sodium 
copper chlorophyllin on hepatitis B therapy (Wong, 1980). As structure of 
pheophorbide a and sodium copper chlorophyllin are similar, they may have similar 
mechanism of anti-HBV action. However, there is no report of how sodium copper 
chlorophyllin act against hepatitis B. The inhibition of Pre SI promoter activity of 
pheophorbide a verified that pheophorbide a suppressed the Pre S gene expression via 
directly decreasing the activity of Pre SI promoter. For further confirmation, it is 
important to further study the anti-HBV effect of pheophorbide a by in vivo animal 
and clinical trial. Although Phyllanthus species have been applied to clinical trials for 
chronic hepatitis B treatment for many years, no significant report was reported (Liu 
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et al., 2001). Therefore, the active component, pheophorbide a was recommended for 
( 
clinical trial in order to prevent the variation of period and place where the botanical 
samples were collected, age of plants and the part of the plant used. 
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